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This capstone reviews the common skin diseases on a global scale. With these dermatoses being 
further funneled into Africa and then magnified into common West African dermatoses, the 
meta-analyses of literature available paints a clear picture of the epidemiological & pathological 
factors and their contribution to the skin disease. Each article analysed in this analysis was taken 
from a 20-year span of January 2000 to December 2019. The selection of articles was fine-tuned 
by identifying the distribution of skin disease, revealing the populations affected (age, gender, 
ethnicity, etc), the main causes, country of origin, the prognosis of disease, and the pathology of 
the specific skin condition. The top 15 common skin diseases of West-Africa ranked by count 
and relative frequency are Atopic Dermatitis (RF: 7.49%), Pityriasis (Tinea) Versicolor (RF: 
4.94%), Acne Vulgaris (RF: 3.73%), Papular Urticaria (RF: 3.47%), Tinea (unspecified 
dermatophytosis) (RF: 2.94%), Contact Dermatitis (RF: 2.94%), Scabies (RF: 2.76%),  
Seborhheic Dermatitis (RF: 2.50%),  Pityriasis Rosea (RF: 2.26%), Urticaria (2.18%), Human 
Pappilomavirus / Viral Warts (1.85%), Tinea Capitis (RF: 1.80%), Lichen Planus (1.77%), 
Vitiligo (RF: 1.77%) and Lichen Simplex Chronicus (RF: 1.45%). Moreover, each 
epidemiological and pathophysiological/pathological factor plays a role in skin disease, and 
unveiling the methods, such as potential immunotherapies and public health initiatives, to 
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II. Introduction   
A. Skin’s Role in Disease 
The skin remains the largest organ at the barrier between the host and the outer world that 
provides the human body with the ultimate security to outside pathogens seeking infiltration. 
When these detrimental insults infiltrate this shielding, crucial tissue function is impaired. This 
impaired function leads to a plethora of diseases such as contact dermatitis, pityriasis versicolor, 
urticaria or atopic dermatitis. This compromised security in the skin now initiates the initial 
innate immune response, that is generally activated as a means to clear such atrocious 
microorganisms. This first response utilizes natural detection of the offensive patterns unique to 
these antigens, whether from the individual or foreign to the individual's repertoire of genetic 
material. Similar but slightly different is the next line of defense, the adaptive immune system. 
After the first attempt to clear the bacterium, virus or other pathogen, this robust family of 
proteins orchestrate a slower response to conclusively clear the tissue of the pathogen (Harris & 
Richmond, 2014). 
 When aberrancies arise in this area, there noticeably happens to be a slew of skin 
disorders that arise with the hiccups. Tumor immunity, allergic reactions, as well as 
autoimmunity are a few of the key players in the most common skin diseases that harass the 
globe. Respectively warts, allergic contact dermatitis, and vitiligo paired with lupus are only the 
tip of the iceberg of  the phenotypic expressions of these immunodermatological adversaries 
(Richard & Harris, 2014). 
Epidemiologically speaking, one can tie together genetic factors that bridge the 
alterations of the genome in relation to skin disease. Although the field of epigenetics is new, the 
epidemiology of skin disease potentially relates to the various stressors of skin disease such as 
stress, consistent exposure to pathogenic microorganisms, socioeconomic status, gender, age and 
more. This paper lightly reviews potential genes and their epigenetic contributions to West 
African skin disease, where literature is scares for this demographic. 
 
B. Skin Disease Worldwide 
The main pillar of this study is to unveil why skin diseases are important to study. Skin 
disease is the 4th leading cause of non-fatal disease burden worldwide. According to the skin 
experts in the Global Burden of Skin Diseases study in 2010, skin disease is additionally the 11th 
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leading cause of disease burden on the country level (Aksut, Dellavalle, & Naghavi, 2017). As 
the skin is the clinical representation of disease, it can be the secondary presentation of a general 
biological process, as these conditions are identified as sequelae of the aforementioned biological 
process. Other factors differ for varying regions surveyed, such as income level and type of 
climate, as covariates contributing to skin disease.  
As children and their loved ones take on the short end of skin disease burden (Mahe, 
2005), women are mostly affected by non-fatal skin disease. However, in terms of aging 
populations above 70 years, eczema, ulceration, non-melanoma skin cancer (NMSC), infections, 
and symptoms such as pruritus, are of major concern (     Ghazizadeh, 2010). In most adults, 
eczema is the leading skin disease related to disability-adjusted life years. These populations and 
the diseases correlated to them must be closely examined as significant relationships can be 
translated to the affected demographic (Hay etl al., 2014). 
 
C. Skin Disease in Africa 
Delving deeper into skin diseases in Africa requires surveying a variety of 
epidemiological variables in regards to which skin diseases are the most common of the top 
global skin diseases. With these diseases in mind, this study will unveil the exact dermatoses that 
are also shared with the general African population. As Africa boasts of being one of the most 
populous continents, with it’s 1.34 billion people as of 2020 and nearly double projected for 
2025 at 2.53 billion.  (U.S. Census Bureau, International Data Base, 2019.)  being centered at the 
equator, skin disease in this continent is expected to differ from the rest of the globe.  
The continent holds a highly tropical (hot, humid) climate with higher seasonal levels of 
UVA and UVB rays. This environment allows for higher production of Vitamin D as well as 
natural selection of individuals with a genetic pool more inclined to pigmentation of the skin 
(Kagotho et al., 2018). This may give reason to the higher concentration of auto-immune 
diseases of pigmented skin, such as vitiligo, one of the top 15 skin diseases that affect primarily 
West Africa. The World Health Organization has shown that this climate, access to clean water 
with poor hygiene, close quartered-living, and insect-bites are prime etiological factors of overall 
detrimental dermatoses in 3rd world countries (MacDonald, 2005). 
With the majority of African countries being developing nations, this study seeks to 
elucidate the factors that have made the aforementioned dermatoses among the most common 
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skin disorders in sub-Saharan Africa. Factors such as fairly high amounts of overcrowding in 
homes, communal use of bedding in poor housing conditions, illiteracy, hygiene contribute to the 
disorder. Scabies is known as the ‘communal’ disease as it directly results from such conditions 
in close-quartered communities (Hay et al, 2012). Similar to the global findings, the population 
most susceptible to these skin conditions in Africa are children as well. This review article will 
shed light on susceptible demographics to skin diseases in Africa. Unearthing these dermatoses is 
weighed on the highly variant factors specific to each region (North, South, East, West, Central, 
and/or Sub-Saharan). These factors include, but are not limited to, geographic location, climate, 
socioeconomic privilege, and epigenetics. To extend further, the continent’s lack of burden 
awareness contributes to the root of the derm issues (Ugbomoiko et al, 2018). 
 
D. Skin Disease in West Africa 
West Africa is comprised of 15 countries: Benin, Burkina Faso, Cape Verde, Cote 
D’Ivoire, Gambia, Ghana, Guinea, Guinea Bissau, Liberia, Mali, Niger, Nigeria, Senegal, Sierra 
Leone, and Togo (2016, ECOWAS). The largest city and country in Africa lies directly in West 
Africa: Lagos, Nigeria. On the other hand, with large populations come large responsibility as 
the access to stable housing (i.e. no overcrowding housing arrangements), clean water, pollutant-
free air, and adequate health care are fundamental in mitigating the pathogenesis of these 
dermatoses. This capstone research will look closely at skin diseases in West Africa, particularly 
in Ghana and Nigeria. For example, in Nigeria, skin disease manifests differently for those in 
Northern and Southern regions by matters of inflammatory and infections/infestations versus 
cosmetic-related dermatoses, respectively (Henshaw et al., 2018).  
As far as skin disesase in Africa, we have varying dermatoses that traverse across the 
respective regions of Africa. The large continent boasts significantly different epidemiological, 
genetic, environmental, and socioeconomic factors in the northern, southern, eastern, western, 
and central regions. For instance, in Egypt, there is an incidence of  vitiligo at a rate of 2.2% (El-
Khateeb, Imam, Sallam , 2011) , while the rate of incidence in Ghana (sub-saharan/West Africa) 
stands at a midly higher rate of  4.16% (Rosoenbaum et al., 2017). Although vitiligo has no 
known preference for race nor gender, this still attests to the multitude of diseases that vary 
across one of the largest continents and most diverse population on the planet. 
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West Africa has a steroid problem. Approximately 70% of Nigerian women bleach their 
skin. Unfortunately, most times, these creams utilized are highly caustic and relatively corrosive. 
With common ingredients such as mercury, steroids and high levels of hydroquinone, these 
creams can lead to major problems with cause major skin irritation and thinning, acne, blisters 
and dangerous chemical burns. At this level of melanin degradation occurring, it can prove to be 
debilitating. Future side effects can possibly include aggressive forms of skin cancer including 





III. Immunology of the Skin 
A. Epidermis: Frontline of Protection 
The skin is comprised of two major layers: the epidermis and the dermis, with the 
underlying subcutaneous layer frequently studied simultaneously (see figure below).  
 
Figure A: Subcutaneous, Dermal and Epidermal layers of the skin against their respective 
dermatoimmune counterparts. Figure B: Additional biological systems of  the skin. (Kwiecien, 
et. al (2019).  
 
Within this triad, there are four structural sections of the epidermis that encompass these 
layers: the stratum basale or basal membrane, stratum spinosum, stratum granulosum, and 
stratum corneum (Bäsler, et al., 2016). There is also stratum lucedum in thick skin such as the 





1. Stratum Basale 
At the base of this 0.1mm thick layer (Chambers & Vukmanovic-Stejic, 2019) is the 
stratum basale, which is comprised of stem cell- like cells, which differentiate into keratinocytes, 
the most populous cells In the epidermis. These epidermal-resident tissue cells are replenished 
throughout the four layers of the epidermis. As they are stationed in the basal layer, this 
monolayer of cells then differentiates apically. Furthermore, specialized cells that reside in the 
epidermis are melanin-shuttling melanocytes that attach to the basal layer and are interspersed 
throughout the epidermis on the border of the dermal-epidermal junction (DEJ) (Yamaguchi, 
Brenner, & Hearing 2007); these cells protect against UV-radiation through pigment expression 
(Chambers & Vukmanovic-Stejic, 2019 ). 
 
2. Stratum Spinosum 
Once these basal keratinocytes traverse upward to the stratum spinosum (prickle cell 
layer, as some like to reference), a process called maturation initiates. The morphology of the 
keratinocytes in the stratum spinosum go from cuboidal to polygonal in order to process the 
keratins specific to the prickle cell layer. Langerhan cells, resident memory T cells and CD8+ T 
cells can be found throughout the stratum basale and the stratum spinosum (Nestle et al., 2009). 
Interruptions in keratinocyte differentiation and aberrant lipid composition in this layer of the 
skin gives rise to skin diseases such as atopic dermatitis and ichthyosis vulgaris. (Palmer et al., 
2006, Smith et al., 2006) 
 
3. Stratum Lucidum 
 The stratum lucidum is the layer of the skin 2-3 cells wide that is soley on the palms and 
soles with little to no hair in this area. This thick layer is comprised of eledin, the transformed 
version of keratohyalin (Yousef, Alhajj, &Sharma, 2020). 
 
4. Stratum Granulosum 
The stratum granulosum is the layer of the epidermis, two layers from the stratum basale. 
This layer has two types of granules: lamellated and keratohyalin. The majority of cell organelles 
are damaged, but the cell is still functional and alive. The 3-5 layers of cells contain keratin that 
aggregates, crosslinks and forms bundles to provide a polygonal and rectangular shape. Lamellar 
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bodies fuse both the stratum granulosum and the stratum corneum to create a continuous bilayer 
during simultaneous production of  keratin proteins, lipids, and antimicrobial peptides (AMPs) 
that allow for the desquamation of cells at the stratum corneum (Yousef, Alhaj, & Sharma, 
2020).  
 
5. Stratum Corneum 
As the keratinocytes flatten out, they then terminate themselves due to their pyknotic 
nuclei, thus these terminal cells of differentiated keratinocytes are void of organelles (Nestle et 
al., 2009). This comprises the stratum corneum. The corneocytes are key contributors of the 
barrier functionality of the stratum corneum by rejecting toxic proteins and arms the skin with a 
watertight barrier that prevents transepidermal water loss to the tissue (Brandner et al., 2014).  
 
B. Epidermal Cells 
1. Skin Stromal Cells 
a.  Keratinocytes 
Keratinocytes are epidermal resident cells which express multiple pattern recognition 
receptors (PRRs) that detect arduous proteins with innate recognition patterns (PAMPS) to 
recruit diverse immune cell populations to battle and localize inflammatory response. The main 
PRRs for keratinocytes are more widely known as the toll-like receptors (TLRs) and nucleotide-
oligomerization domain- like receptors (NLRs). Specific to these stratified cells, TLRs 1,2, 3, 4, 
5, 6, 9 and 10 (Kollish et al., 2005,) which specifically bind to their respective linds to recruit 
antimicrobial organisms, or antimicrobial peptides (AMPs) to ward off pathogenic insults to the 
epidermis and maintain homeostasis of the skin microbiome. As the TLRs are grouped into two 
categories of cell surface (TLRs 1,2,4,5,6) and intracellular (TLRs 3,7,8,9) to recall emblems on 
bacteria, viruses, or fungi. TLR-10 is not ligand-specific yet, as researchers are still seeking to 
find its true partner. Each designated TLR recognizes patterns in microorganisms that are 
specific to the genetic instruction of the protein. (Klicznik, Szenes-Nagy, Campbell, & Gratz, 
2018). These cell-specific membrane proteins induce NF-κB and interferon-regulatory factors, 
transcription factors that direct the creation of cytokines used to combat inflammation and type I 
interferons (IFNs), respectively (Kawamura, Ogawa, Aoki, & Shimada, 2014). 
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 In addition to this cascade effect, the keratinocyte-specific TLR3, generates the cytokines 
interleukin-6 (IL-6) and tumor necrosis factor alpha (TNFɑ) which influence gene expression 
and keratinocyte proliferation, and barrier restoration (Borowski et al., 2013, Klicznik, Szenes-
Nagy, Campbell, & Gratz, 2018). It has been established that IL-1ɑ, IL-25, and IL-33 are stored 
strategically for rapid release in the presence of nearby proteases upon injury (Dickel et al., 
2010). After a point of barrier infiltration is sensed, keratinocyte express chemokine ligands such 
as the CXCL20 and CCL27 to induce adaptive and innate immune responses (Kennedy‐Crispin 
et al., 2012). These proteins then recruit and present to CD4+ T Cells and CD8+ T Cells though 
their compatible chemokine receptors CCR6 and CCR10. 
b. Melanocytes 
Melanocytes are the pigment carrying cells that reside in the epidermal-dermal junction 
(DEJ). Melanin is produced through these cells and also contributes to the innate immunity in 
regards to the vascular endothelial growth factor 165 (VEGF165) being upregulated in 
melanocytes through exposure to ultraviolet B . This increased expression of the VEGF ligand 
induced cell proliferation, in both normal melanocytes and under hypoxic and oxidative stress 
conditions, with an influx of cells undergoing melanogenesis (Zhu et al., 2020). This is the key 
cell destroyed in the autoimmune disorder vitiligo. 
c.. Merkel cells (MCs) 
Merkel cells (MCs) are the nerve cells of the skin which are heavily involved in the 
endocrine and nervous systems. In addition to the neuro-endocrine system they are important in 
mechanoreceptor and nociceptive responses. In immunity, MCs highly express the CD200 
protein, which is crucial in inflamed environments as well as immunity tolerance. These cells 
produce the neuropeptide calcitonin-gene related peptide (CGRP), which can prevent Langerhan 
cells from presenting antigens within the epidermis. As intermediates of inflammatory 
mechanisms, stromatin, and the vasoactive intestinal peptide (VIP) are a few proteins secreted by 
MCs (Abraham & Mathew, 2019). In relation to skin disease, upregulation of MCs in psoriatic 







2. Innate Immune Cell Demographics (Bone Marrow-Immune Cells) 
Langerhan Cells 
The epidermis is sporadically entangled with a main type of macrophage population such 
as the Langerhan Cells (LC’s). Furthermore, these cells also have the capabilities to renew 
themselves (Hoeffel et al., 2012). Although LCs have been revealed previously to commit to 
induce tolerogenic responses and simultaneously responding to immunogenic signals and 
presenting immunogenic surface phenotypes (Shklovskaya, 2011), the cluster of differentiation 
transmembrane lectin receptor Langerin (CD207) is the standard trait for identification of 
Langerhan cells. These lectin proteins initiate the formation of Barbick granules, key markers in 
mouse and human epidermal tissue (Valladeau et al., 2000). Langerhans also express CD1a, 
CD11b, CD11c, with major histocompatibility complex II (MHC-II), and F4/80 surface protein 
to identify the immunophenotype of these cells (Guilliams et al., 2014). Upon recognition of a 
mannose-PAMP on a ligand antigen, the LC’s CD207, langerin receptor forms a complex with 
CD1a and translocates an antigen through exocytosis, in the Birbeck granules. These antigens 
presenting epidermal-resident cells are strong dendritic players in immune responses of the skin, 
as this is their primary function (Tsepkolenko et al., 2019). Langerhans are able to express the 
matrix metalloproteinases (MMPs) that are essential to vasodilate blood vessels for them to 
extravasate through the basal membrane to reach the specific lymphatic pathways (Ratzinger et 
al., 2002). MMP-9 and MMP2 are the trafficking regulators in Langerhan cells as MMP-9 and 
MMP-2 deficient murine skin models showed alarming rates of inhibitory migration of LCs into 
the skin at rates of roughly 30-50%.(Ratzinger, 2002). From an immunological standpoint, LCs 
are crucial for the calling of T follicular (TFH) cells. Depletion of Langerhan cells, as recent 
studies have shown, decrease TFH cells by nearly roughly 50% in adaptive response during 
intradermal (ID) immunization while germinal center (GC) B cells were also reduced by nearly 
60% (Levin, et al., 2017). 
 
C. Dermis: Vascular Motherboard 
While there is no blood supply in the epidermis, the inferior dermis layer is stationed with  
substantial amount of blood vessels, extracellular matrix proteins that house collagen, the 
connective tissues reticulin (the type III collagen fiber) & elastin, along with immune sentinels. 
These immune ‘soldier-like’ cells include dermal dendritic cells (dDCs),  plasmacytoid dendritic 
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cells (pDCs), and the highly responsive T cell subsets: CD4+,  T helper 1 (TH1), T helper 2 
(TH2) and T helper 17 (TH17) cells, γδ T cells and natural killer T (NKT) cells. To champion 
these immune cells on are more inflammatory players such as dermal fibroblast cells (dFBs), 
macrophages and mast cells (Nestle et al., 2009). The first of two layers are the papillary and 
reticular layers that lie in the upper and lower areas of the dermis, respectively.  The papillary 
layer supplies the epidermis with nutrients necessary to generate keratinocytes, while regulating 
the temperature of our skin and body. This layer provides the blood vessels and expels waste that 
would otherwise kill skin cells to aggregate. The reticular layer provides the skin with elasticity, 
which allows for our skin to bounce back into it’s original form when interrupted. This deep 
layer includes hair follicles, sebaceous glands, and other sweat glands that are apart of apocrine 
or eccrine glands (Brown, 2018).  
 
1. Active Cells 
a. Fibroblasts 
Dermal fibrolast cells are the substantial proteins throughout the vascular dermis layer in 
concert with dermal-resident stromal and immune leukocytes. These cells are readily accessible 
through vasodilated plasma vessels upon inflammatory response. As they are the warehouse of 
collagen, elastin, and other structural-cell production, they additionally initiate and amplify 
signal transduction during inflammation. These structural cells carry all TLRs 1-10 which is 
significantly higher than their expression of keratinocytes within the epidermis. For instance, 
activation of these TLR4 in the dermis results in a high-fold increase of cytokines induces IL-6, 
IL-8, indicating the supreme role of dermal fibroblasts in immune response (Cheng et al., 2015). 
Specifically, these fibroblasts express the cytokines interferon γ (INFγ), TNFα, IL-12p70 and IL-
10. Of course, more extensively than the keratinocytes, the dermis secretes the chemokines 
CCL1, CCL2, CCL5 and the chemokine motif ligands CXCL1, CXCL8, CXCL10 and CX3CL1. 
Furthermore, the growth factors and growth factors granulocyte/macrophage colony-stimulating 
factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) becoming stimulated upon 
fibroblast activation. On the other hand, these fibroblasts are also known to divert T-Cells to a 





b. Endothelial cells 
Endothelial cell populations are lined among the blood vessels of the dermis and have surface 
molecules that can detect and initiate a response from stimuli in the environment. As these 
PAMPs recognize foreign patterns, they elicit responses that resemble unique characteristics of 
traditional, innate immune cells. The unconventional endothelial and epithelial cells contain E 
and P selectin, Fc- receptors, proinflammatory cytokines such as TSLP, IL-33, and IL-25 (Roan, 
Obata-Ninomiya & Ziegler, 2019). These signals are sufficient in their tactics to behave as 
antigen presenting cells (APCs) to B and T cells throughout the skin (Mann et al., 2012). 
When speaking about key players in the dermis, note that during inflammatory response, 
structural fibroblasts in the dermis differentiate into these dermal white adipose tissue cells and 
then secrete the AMP, cathelicidin Although fairly de novo, recent studies have shown AMPs 
roles in the skin,  primarily involving their origin in the subcutaneous layer and the 
pilosebaceous glands. (Chen, Zhang, & Gallo, 2019). 
c. Myeloid dermal dendritic cells 
Myeloid dermal dendritic cells are the family of myeloid progenitor cells that eventually 
differentiate into mature dermal dendritic cells in the lymph. Once activated, these DC 
populations mature post-exposure to PRRs and drain to their localized (dermal) lymph nodes. 
Once these cells complete differentiation, the result is two specific sub-families of dendritic 
cells. The CD103+ with CD141+ and the CD1C+ and CD11b+ cells are the key myeloid dermal 
macrophages which initiate antigen presentation. Macrophages also express F4/80 and CD11b 
markers, but do not express the novel Langerhan cell markers, CD207 and CD11c. The lack of 
the MHC-II complex on these cell populations halts these cell’s activity in the downstream 
activation of the adaptive immune response (Guilliams et al. 2014). When looking into skin 
disease, atopic dermatitis’ immunology intimately involves the activity of myeloid dendritic 
cells.  The chemokines CCL22 and CCL17 are released upon activation and recruit Th2 cell in 
the acute phase of this condition. (Kashem, Haniffa, & Kaplan, 2017).  
d. Plasmacytoid dendritic cells (pDCs)  
In relation to injury to the skin, recent studies have shown after 24 hours post-injury to 
murine skin, plasmacytoid dendritic cells’ (pDC) presence parallels with upregulated mRNA 
gene expression of both IFN alpha-and beta (Gregoria et al., 2010). Additionally, the expressed 
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TLR7 and TLR9 are vital for immune responses. Guiducci and colleagues unveiled that treating 
pDCs with an oligonucleotide antagonist, blocked TLR 7 and TLR 9 expression and discovered 
this to significantly reduce fundamental inflammatory cytokines, including IFN-alpha. 
(Guiducci, 2010). Furthermore, downregulation of pDCs are directly correlated with 
downregulation of IL-6 and Th17 cytokines IL-22 and IL-17, indicating the necessity of these 
proteins in inflammatory conditions such as tape-stripped murine skin. IL-6 is a key cytokine 
involved in the keratinization of wounded skin that contributes to rebuilding the epidermis of the 
skin (Gallucci et al., 2004). As these cells are the primary immune cells in autoimmune disease, 
such as vitiligo, interactions with the heat shock protein 70 (Hsp70), create the prerequisite IFN-
alpha in vitiligo patients (Jacquemin, et al., 2017).  
e. Mononuclear Phagocytes 
Within the skin, the mononuclear phagocytes are monocytes and macrophages that exist 
within circulation and tissues, respectively( Hoeffel et al, 2012; Knipper et al., 2015). Similar to 
the  pDCs, these cells carry a wide range of the PRRs, TLRs, thus having the capabilities to 
detect key PAMPs within dermal inflammation. The previously mentioned LCs and dermal 
macrophages comprise the two major classes of macrophage demographics in the epidermis and 
the dermis, respectively. As we are familiar with the LCs, macrophages also carry the capacity to 
express the surface markers F4/80 and CD11b. However, they differ by their lack of expression 
of CD11c nor Langerin with lower MHC-II glycoprotein (Minutti, Knipper, & Allen, 2017). As 
aforementioned, we are familiar with LCs activity in injury and skin aberrancies, in reference to 
dermal macrophages, studies have identified this population of mononuclear phagocytes as the 
main source of VEGF in the vital process, angiogenesis, of early wound repair (Willenborg, et 
al., 2012). 
f. Resident Macrophages 
Resident macrophages are a distinct phagocytic cell that arise from the monocytes in the 
blood. These macrophages, called M1 cells, come about through collecting at the site of 
inflammation in response to injury (Mantovani et al., 2004). As these cells are also able to 
secrete various cytokine proteins for adequate function within the skin’s innate immune 
response, they do also carry the PRR that allow them to behave as prominent phagocytes and 
bactericides. Upon their activation, the aforementioned cytokines initiate antigen processings, 
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along with phagocytosis that precedes the necessary growth factors (VEGF, KGF, etc) that are 
active in wound healing. The other resident macrophage family cells, the M2 macrophages are 
the primary sources of IL-10, to generate T-Helper 2 Cells (Th2 cells) ( Gerber & Mosser, 2001). 
Recent studies that have reviewed how the skin utilizes resident macrophages during wound 
repair and secrete the cytokine IL-4. This released cytokine is used to organize the collagen 
fibrils post direct insult to the epidermis. Without this key cytokine available, the levels of lysyl 
hydroxylase2, (LH2), are lowered, thus stunting the necessary collagen cross-links that are 
needed during reconstruction of wounded skin (Knipper et al., 2015). With this in mind, the 
macrophages withhold the ability to generate fundamental molecules that mediate the production 
of the skin collagen’s structural synthesis. 
 
D. Hypodermis: Thermal Regulation and Anti-Microbial Protection 
The hypodermis is primarily composed of adipocytes that serve to intentionally store fat 
to provide a multitude of advantageous services to the skin. These dermal white adipose tissue 
cells (dWATs) are essential in attenuating homeostatic capabilities of thermogenesis, by 
expansion in exposure to cold temperature. dWATs orchestrate defenses against microbial 
pathogens that give rise to bacterial infection, support adequate wound healing and champion 
healthy hair growth (Alexander et al., 2015). This essential layer has been elucidated in a murine 
study where dWATs expand in the presence of the bacterium Staphylococcus aureus, thus 
releasing the antimicrobial peptide cathelicidin, killing off the invasive bacteria (Zhang et al., 
2015). This process, deemed reactive adipogenesis, takes place in the pilosebaceous gland 
adnexal to the hair follicle. In this process, as the dWATs take on a conical shape in the 
hypodermis, mature adipocytes generated from preadipocytes increase expression of  
(peroxisome proliferator-activated receptor γ) PPAR-γ and CEBP-α, to produce adipokines, a 
family of inflammatory cytokines (Zhang et al. 2018). Another study conducted noted that 
uncommitted embryonic cells to (the precursor cells of dWATs) aged adult dermal fibroblast 
cells(dFBs) are susceptible to transforming growth factor beta (TGF-β) pathway that inhibits 




Figure B: Hierarchy of the cellular components of the skin. (Nestle et al., 2009 ) 
 
E. Non-Specific Immune Cells 
1. Granulocytes (polymorphonuclear cells) 
 a.  Mast Cells 
Mast cells are daughters to the precursor myeloid progenitor cells. These cells are 
grouped with resident immune cells which release granules upon activation during skin tissue 
injury (Cardamone et al., 2016, Igawa & Nardo, 2017). This release is initially done by excretion 
of histamines, including but not limited to, serotonin, heparin and a myriad of enzymes. This cell 
population is the key mediator of hypersensitivity environments (i.e., allergies). Their early stage 
cells, the mastocyte, are the producers of VEGF, FGF and the nerve growth factor 
(NGF)(Cardamone et al., 2016). Once these cells are activated, they hold the functionality of 
antigen presentation. Once this process occurs, mast cells then release TGF-β1 amongst other 
proteases to induce collagen fibrils and cellular effects due to fibroblast generation. In closing, 
these cells are also necessary for proliferation and differentiation of skin cells in conjunction 





b. Neutrophils  
When identifying respondents during infectious conditions, neutrophils are first in line. 
As they are mainly identified by their DNA extracellular traps (NETs) which allow for engulfing 
of pathogens sensed during infection, these cells are crucial in wound healing models. As they 
travel from the blood to the localized inflammatory site rather quickly, it is clearly evident that 
these cells are at the forefront of protective wound healing. These cells also are able to generate 
the metabolic intermediates that produce an instant “oxidative burst”. In neutrophils, the released 
chemokines are the result of activation of stratified keratinocytes. After this, there are blood 
platelets that garner the neutrophils to the area of injury. These specialized neutrophils can 
identify pathogens through the TLR-1, TLR-2 and TLR-10. They can be developed and activated 
through IL-17, IL-23, and the granulocyte-colony stimulating factor (G-CSF) which is the 
glycoprotein which simulates and releases granulocytes (in this case neutrophils) into the 
bloodstream. Cytokine IL-8, which is synonymous with the chemokine receptor 1 and 2 
(CXCR1, CXCR2), plays the leading driving role of the chemotaxis. The key receptors in 
relation to the immunity of the skin and neutrophils are the chemokine ligand 12 and the 
chemokine receptor 4 (CXCL12), CXCR4). As these specialized granulocytes are able to use 
their enzymes to degrade pathogens within phagocytic cells, it is translated to the firm 
understanding that neutrophils are crucial mediators in wound healing (Wilgus, Roy, & 
McDaniel, 2013).  
Studies have shown that patients with abberencies in their shuttling of granular 
neutrophils demonstrate greater risk for skin infections post-injury and complications during 
wound repair (Tsepkolenko, et al., 2019). Neutrophils are the main warehouses for matrix 
metalloproteinases (MMPs) by way of the granules and other vesicles of the cells. Specifically, 
MMP-2, MMP-8 and MMP-9 are the proteases whom’s abilities were examined closely in 
wound healing. MMP-8 (aka collagenase-2) transcript mRNA levels are upregulated during 
wound sealing as a MMP-8 knockout mice showed a significant lag in wound closure, parallel 
with decreased levels of neutrophil extravasation. This is a clear indicator of MMP-8’s 






c. Eosinophils  
Eosinophils are decorated throughout the dermis and are key identifiers during allergy. 
The TLR receptors on these granulocytes are TLR-1, TLR-4, TLR-7, and TLR-10. The 
specialized cytolysis pathway has spearheaded the unloading of granules in eosinophils such as 
the major basic protein (MBP),  the eosinophil cationic protein (ECP), and the peroxidase 
derived neurotoxin (EDN). These cells are able to fight against viral pathogens upon their 
activation of the granulocyte basophils and their daughter cells, mast cells. This double 
amplification generates a significant response in skin injury models. These eosinophils are 
fundamental in a caustic response during immune responses and stimulate the mediators 
involved in keratinocyte migration (Larouche et al., 2018). 
 
d. Basophils  
Basophils are effector cells that are specifically active in the innate immune system. 
Furthermore, the group of basophils which reveal TLRs-2, 3, and 4 provide these cells with their 
protective characteristics. These cells also have regulatory traits where they monitor the traffic of 
eosinophils by expressing the vascular cell adhesion molecule (VCAM-1) in endothelial cells. In 
reference to UV exposure in the skin, basophils have been shown to be active in combating 
inflammation as a large amount of these cells have been found in patient biopsies, thus 
elucidating the basophil’s role in skin inflammation. (Voehringer D, 2017). They release 
histamines and cytokines IL-4, IL-14, and IL-3 to be involved in vascular permeability 
(Buckland, n.d.). 
 
2. Natural Killer Cells 
Although the design of these cells is morphologically absent of T and B cell markers, 
natural killer cells can still induce cytolysis, the process of cells bursting due to an osmotic 
imbalance within the cytoplasm. One of their main functions is to generate the cytokine family of 
interferons (IFN-γ) to assist in removal of tumor cells and clearing viral infections. The TLRs 
they express are TLRs 3,7, and 9. Other PRRs that belong to these cells are NOD2 and NLRP3 
(Qui et al., 2010). During inflammation, these natural killer cells will localize to the skin using 




3. Innate Lymphoid Cells (ILCs) 
Innate lymphoid cells (ILCs) are a group of cells that have a colored resume of cytokines 
and transcription factors they can produce and express, relatively. Although these cells have 
different surface markers than B cells, DCs, T Cells, granulocytes and macrophages, they do 
have the cluster of differentiation markers 90, 25, and 127 (CD90, CD25, and CD127). These 
cells are part of a family of immune cells that are heterogeneous in their cytokine production 
profiles, transcription factor expression and effector functions. ILCs come from a familial 
lymphoid progenitor cells, and then future growth is dependent on CD132, the cytokine IL-7, the 
type-1 transmembrane proteins in concert of the Notch signaling pathway, and the DNA-binding 
protein inhibitor (ID2) gene (Björkström, Kekäläinen, & Mjösberg, 2013).  
 Innate lymphoid cells are then broken into categories of developing transcription factors 
paired with cytokine and cell lineage markers. Group 1 includes ILC’s which produce IFN-γ 
from T-bet transcription factor. Group 2 ILCs are reliant on transcription factors GATA3-, 
RORα-, and TCF-1 and generate cytokines IL-5, IL-9, IL-13 and amphiregulin. Group 3 ILCs 
are dependent on RORγt and generate cytokines IL-17A, and IL-22. The ILC1, ILC2, and ILC3 
groups are symmetrical to the adaptive cell groups Th1, Th2, and Th17 CD4+ T helper cell 
population. While ILCs do parallel the functionalities of CD4+ T cells, these phenotypically 
distinct cells are specific to respond in innate immunity alerts where there is no specific antigen 
necessary (Kim, Wojno, & Artis, 2013). ILCs can be found in the vast majority of tissues, they 
are saturated in the gut, skin and lung as active players in tissue homeostasis and inflammation. 





Table 1:  A comprehensive makeup of the skin’s innate and adaptive cells present in homeostasis 
and during injury. There are key identifiers of these cells and the cytokines/chemokines that they 
release as well as the localization of these cells. This table concludes the literature in this section 
into a clear conglomerate of the epidermal and dermal cells. 
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F. Adaptive Immune Cell Demographics  
 1. Epidermis 
While the Langerhan cells reign as one of the top contenders throughout the epidermis, 
the skin-resident memory T cells are first in line during adaptive immune responses to secondary 
antigens, serving as key effector cells. The skin houses two times as many T cells than in the 
blood in addition to having 98% of cutaneous lymphocyte-associated antigens stationed in the 
skin during physiological circumstances (Boyman et al., 2006). In psoriatic skin, lesions develop 
quicker than healthy, normal skin in murine models without type I and type II IFN receptors 
(Boyman et al., 2004). With this presented deficiency in immune regulatory proteins, the 
necessity of skin-resident memory T cells is worthy of investigation. Following the 
aforementioned study, researchers looked into the kinetic activity of T cell expansion in psoriatic 
skin, discovering a significant increase in dermal T cells prior to the progression of psoriatic 
transformations in the epidermis (Conrad et al., 2007). As these changes occur once T cells cross 
into the epidermal basal layer, the conclusive discovery of T cell activation and their expansion 
is a precursor to the pathology of the epithelium stands supported. Additionally, the dynamic 
relationship between basal T cells and keratinocytes is fundamental for this epidermal 
pathophysiology. The very late antigen 1 (VLA1/ α1β1 integrin) expressed on basal membrane T 
cells and it’s interaction with collagen IV, provides a key pathway for migration of the skin-
resident T cells (Wakim et al, 2008). In addition to VLA1, skin-resident memory T cells have 
also been shown to express CD103 for skin homeostasis and protection against harmful 
pathogens (Gebhardt et al, 2009). 
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Human Simplex Virus infections also show the relevance of skin-resident memory T cells 
in immune response. A mouse model showed that the skin-resident memory T cells and CD4+ T 
cells provide the proliferation of memory CD8+ T cells (Wakim et al., 2008). Studies outside of 
human skin models show that there are three specific phases of immune responses involving T-
Cells. The first is mainly of tissue-resident memory T cells, the second is the gathering of non-
specific circulatory memory T cells and the third involves  antigen-specific T cells that drain to 
the lymph nodes (Woodland & Kohlmeier, 2009). This provides a clear understanding about the 
importance of skin-resident memory T- Cells in the immunogenesis of skin conditions. 
 
αβ T lymphocytes 
As aforementioned, these are cells that congregate at the epidermis through circulation in the 
blood and chemokines secreted by local keratinocytes. The affinity of  these T cells to the 
epidermal tissue is a result of the cutaneous lymphocyte antigen (CLA+) T cells via the vascular 
lectin endothelial cell-leukocyte adhesion molecule (Berg et al., 1991).  
 
2. Dermis 
a. CD4 + T Cells 
TH1, TH2, and TH17 cells are the main types of CD4 + Tcells found in the skin during 
inflammatory skin disease. In times of infection of the skin, Th1 cells that produce IFNγ can 
activate macrophages and kill pathogenic organisms in between cells. In normal conditions, Th1 
cells are associated with autoimmunity and pathologies related to immune-driven conditions as 
in psoriasis. TH2 cells moreso are connected to allergic disease such as eczema (atopic 
dermatitis) and allergen-stricken diseases, whereas TH17 cells have recently been tied to roles in 
psoriasis (Di Cesare, Di Meglio, & Nestle, 2009) and atopic dermatitis while being at the 
frontline against a multitude of fungal and bacterial infections (Weaver et al., 2007). To further 
indulge in TH17’s potential responsibility for skin disease such as chronic mucocutaneous 
candidias is due to a perturbed IL-17 (the cytokine released by TH17) mediated immune 
response based on genetic defects which unveils autosomal-dominant hyper-IgE syndrome as 
well as autosomal-recessive vulnerability to mycobacterial disease (Eyerich et al., 2008). These 
diseases related to the CD4+ T cells are identified by the frequent and repetitive mucosal and 
skin membrane infections. As mentioned previously, a presumed mechanism for the battle 
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against pathogens with IL-17 and IL-22 responses in the skin is due to the upregulation of AMP 
production via epidermal keratinocytes. As these are cytokines released by TH17 cells, these 
subset of T helper cells connect immune and epithelial cells to optimize the host’s immune 
response against foreign dermal pathogens. There has been a subset of T cells that specfically 
secrete IL-22 cells, titled TH22, recently unveiled. In the presence of  IL-6 and the TNF family, 
plasmacytoid dendritic cells are effective in generating these TH22 cells. Similar to Th17, these 
cells have also been seen in skin of patients with atopic dermatis; understanding their future role 
in skin pathogenesis and homeostasis is ideal for the future of dermatological science (Nograles 
et al., 2009). 
b. γ Delta T Cells  
Another cell type in the dermis includes the γδ T cell subset which are identified by the γ 
and δ T Cell receptor (TCR) chains. They are thymic progenitor cells that have grown and 
survived elsewhere in the periphery and consitute for up to 5% of these peripheral, CD3+ cells 
post-synthesis of embryogenesis (Bonneville et al., 2010). As these γδ T cells are barrier-tissue 
resident cells that are present in both human and mice cell lines, the morphology of mice γδ T 
cells takes on a more dendritic form while human cells are more peripheral blood cells. γδ T cells 
localize based on the chemokine receptors expressed by way of released cytokines via epidermal 
keratinocytes (Havran, Chien, & Allison, 1991). The majority (over 80%) of these cells do 
express the CCR5 that shuttles the migratory transport of γδ T cells to the localized inflammatory 
area. γδ T cells have a small inventory of recognizing antigens. Their capabilities include not 
needing main histocompatibility complexes (MHCs) and costimulating molecules (CD28, CD30 
etc.) to respond and recognize antigens due to TLR-1 and TLR-3 that recognize PAMPs (Havran, 
Chien, & Allison, 1991). The inflammation created causes an increased expression of the NOD-
like receptor-4 (NLR-4). γδ T cells are able to improve the anti-infectious resistance through 
mainly generating IL-17 aftter they migrate to the dermal area post-infection of bacterial 
pathogens or injury. The decreased activity of delayed-type hypersensitivty effector cells, 
alongside the generation of IFNγ, activating dendritic cells, and aiding in maturation and 
cytokine productions (Cruz et al., 2018). These γδ T cells identify stress proteins in the presence 
of the transmembrane proteins, NKG2D and NKG2. Immediately after this, these γδ T cells, 
synthesize chemokines, cytokines, effectors(IFN-γ), and keratin growth factors (KGFs)  locally 
thus inducing cell lysis (Cruz et al., 2018). γδ lymphocytes are the first responders to skin trauma 
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and can rapidly alter their morphology. The activation tissue marker, CD69,  is expressed and 
thus produces chemokines that recruit inflammatory cells to the cellular matrix (Marshall et al., 
2019). These actions are able to regulate inflammation, cellular cytotoxicity and wound healing. 
Furthermore, these cells can interact with keratinocytes, helping their survival and function, to 
aid in rebuilding the epidermis upon direct damage. 
 
 c. Natural Kill T Cells (NKT) 
Natural Killer T Cells (NKT) are apart of the innate immune system, although they are 
thymic cells. These NKT cells are different cells in that they only have an invariant V alpha-14 
and Vbeta-11 rearrangement receptor in humans (Godfrey et al., 2004). This Valpha-24 and 
Vbeta-11 rearrangement receptor provides NKT cells to identify antigens specific to glycolipids 
by way of the antigen-presenting molecule CD1d on MHC I (Sieling, 2000). Most molecules 
associated with these lymphocytes are located in the periphery. As for the lymphatic cells in the 
bloods, the NKT cells are roughly 1% of the entire population, and are at a significantly lower 
rate in the dermis. They are the main sources of the IFNγ and other cytokines in regards to 
pathogenic defense. Outside of IFN-γ, IL-4 also participates in the antigen-specific, CD8+ T-cell 
and dendritic cell function in resident tissue (Sielling, 2000).  
 
 d. B-Lymphocytes in the Dermis 
B Cells from the humoral stem of the immune system are the primary source of specific 
antibody producution. These cells also can operate outside of antibodies and acts as APCs to then 
generatie cytokines both locally and systemically. There are a vast variety of emerging studies 
that reflect B cells having a significant role in dermatoses and homeostatitc skin conditions. The 
proinflammatory and immune regulation of Bcells have also deemed them essential amongst the 
tumor microenvironment of melanoma afflicted skin. As we garnish more information from 
mammaliam skin models, the idea that B lymphocytes are apart of the dermal immune system 
gains further confirmation (Egbuniwe, Karagiannis, Nestle, & Lacy, 2015) 
In the skin, the CLA guides T cells to the skin. The antigen binds to the surface adhering 
protein E-selectin that is upregulated under vasodialation in inflammatory conditions in the skin. 
However this protein is rather low in levels of normal, non-inflamed skin. The CLA protein is 
expressed in circulatory, memory B cells that are also upregulated in vitro. This method of 
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upregulation enhances CLA binding to e-selectin and supports the notion that proper stimulatory 
conditions will induce the CLA binding process in B lymphocytes as a means for cutaneous 
migration. However, other e-selectin ligands are expressed on B cells as there are different 
isofroms of glycoproteins that the CLA antigen falls under. In regards to the skin, less is known 
about the receptor-ligand couples that do control the B cell homing in cutaneous 
microvenvironments (Egbuniwe, Karagiannis, Nestle, & Lacy, 2015). 
 In normal skin of mice and humans, skin-associated B Cells do recirculate or are skin-
resident. They localize to the deep dermis whre they then are spread out individually in 
homeostatic conditions as either clusters or lymphoid structures. These heterogenous cells 
include conventional B-2 cells and B-1 cells. There is a suggested subset of B cells that resemble 
the conventional B-2 cells which express high levels of IgM and cell surface markers such 
CD11b. These B cells identify pathogens and generate organic Abs sans T-Cells at the beginning 
of infection, mostly IgM and IgA and in murine models, the cytokine GM-CSF. In regards to 
human skin models, secretion of IgA is found in eccrine sweat glands, sebum and sweat. The 
antibody secretion of IgG and IgM is found at the skin surface, although this route is unknown. 
Interetingly enough, IgG in sweat found on the skin surface can bind commensal bacteria S. 
aurues.  As the origin of these Abs are to combat and regulate skin pathogens, they can be 
detrimental to dermal autoantigens in an automated antibody process (Debes & Mcgettigan, 
2019). 
 B lymphocytes are genrally considered to be systemic, thus contritbuting to autoimmune 
and inflammatory skin diseases. The nubmers are upregulated in dermatoses such as psoriasis, 
scleroderma, atopic dermatitis, allergic contact dermitis and more. Further studies need to be 
conducted to identify whether or not B cells contribute to inflammation of the skin through 
localized effector fuctions as these cells are infiltrating the tissue in a number of dermatose 
pathologies. Upon their activation, B lymphocytes are known to be effector cells in inflammation 
as they secrete a number of inflammatory cytokines such as GM-CSF, IL-6, IFN-γ, and IL-4. 
Recent studies have shown that during skin fibrosis and thickening, skin pathology had been 
reduced in B cells that lacked expression of IL-6, showing pathogenic roles for this cytokine-
lymphocyte axis. Furthermore another subset of B Cells are regulatory B cells that involve 
exrpression cytokines Il-35 and Il-10, maintainence and widespread production of regulatory T 
cells, and adenosine generation. In wound healing models, scientists propose TLR-4 induces 
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upregulation in IL-6, IL-10, TGF-beta, PDGF, and FGF for the source of B-Cell generated 
wound healing. As this is a relatively new field in dermatoimmunology, more studies can look 
into the subsets of B-cells and their role in wound healing therapeutics (Debes & Mcgettigan, 
2019). 
G. Most Common Dermatoses 
Eczema, psoriasis, acne vulgaris, pruritus, alopecia areata, decubitus ulcer, urticaria 
(hives), scabies, fungal skin diseases, impetigo, cellulitis, viral warts, molluscum contagiosum, 
non-melanoma skin cancer, abscess and other bacterial skin diseases are the 15 most common 
dermatoses of the world  (Johns et al, 2013). Uncovering the impact of these specific skin 
diseases provides direct suggestions as to what doctors should be leaning towards when it comes 
to public health matters. Through following the cascade of burden globally, dermatological 
scientists and skin biologists must converge their thinking into strategic management and control 
of skin disease which efficiently and necessarily utilise health resources in addition to 
withholding the rank of dermatoses in comparison with other diseases. 
 
IV. Statement of Purpose 
The purpose of this review is to understand the epidemiology and pathophysiology of 
common skin diseases affecting the people of West Africa. Primary contributors to these 
common diseases found not only globally, but additionally funneling through, Africa and West 
Africa were identified in order to make recommendations for improvement of dermal healthcare 
regulations. 
While other research has focused on identifying the epidemiology of skin disease in these 
regions through direct patient surveying and clinical observation by medical professionals and 
self-referrals, this research will specifically focus on updating and quantifying these 
epidemiological factors that may give rise to the full scope of these the region rather than 
specific countries. As a result of this research, specific recommendations to lessen the burden of 
skin disease, particularly in the Economic Community of West African States (ECOWAS) 





V. Methods of Literature Review 
Skin disease is categorized through the International Classification of Diseases, Ninth 
Revision (ICD-9), as well as diseases of the hair, nails, eyelids, external genitalia and ear. In 
addition any damage done to the skin from outside causes are grouped into this  ICD-9 category. 
From this definition, according to the Journal of American Academy of Dermatology, there are 
24 categories that group these diseases into one space. 
Each article analysed in this analysis was taken from a 20-year span of January 2000 to 
December 2019. The selection of articles was fine-tuned by identifying the distribution of skin 
disease, revealing the populations affected (age, gender, ethnicity, etc), the main causes, country 
of origin, the prognosis of disease, and the pathology of the specific skin condition. Studies were 
included that were conducted from observational inpatient/outpatient clinics in West Africa 
without exclusion of any group. Each article reviewed includes observational studies by general 
practitioners, internists, dermatologists, and/or nurse practitioners in the area. When identifying 
the immunopathologic pathways, there are genomic markers and factors that contribute to the 
phenotypic expression of these immune responses. To understand the pathology of each skin 
disorder, peer-reviewed scholarly journal articles were used for the general guidance of the 
prognosis as well as for the explanation of the pathogenesis and pathophysiology of each disease.  
Studies were exclueded that found skin disease as sequale of larger disease studies (HIV, 
AIDs, diabetes etc). The focus of the review was to include solely West African disease 
including studies related to scabies,  studies that included solely one demographic (i.e children), 
as well as studies that included specific regions of varying areas (rural and urban areas).  Studies 
that covered all types of skin disease were included in order to get an full visual of any skin 
disease found in West Africa. Articles that are literature reviews of direct observational studies 
served as a reference for framework of this paper, but their direct findings were not included in 
statistical skin disease analysis, although they may have similar findings. 
24 research articles that spanned over four West African countries: Benin, Cameroon, 
Ghana and Nigeria. Each article contributed a portion of the total patient count that relates to the 
total frequency of disease frequency. Benin studies contributed a total of 246 patients, Cameroon 
contributed 248, Ghana contributed 3,900 and Nigeria contributed 31,762 patients to the study. 
The total amount of patients surveyed was 34,709. The relative frequency is calculated by the 
(frequency of disease)/ (total frequency of disease). Each of these studies reported their 
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prevalence rates through tables. After the diseases were compiled in one tables, the dermatoses 
were then sorted by relative frequencies from the largest to smallest of the top 15 Dermatoses. 
There are over 400 diseases that were organized into 24 categories through Fitzapatrick’s 
Dermatology, a standard guideline in dermatology. The top 15 dermatoses went through a 2- 
sample z test for equality of proportions for West Africa vs the United States. One study was 
used to identify the relative frequency of dermatoses in the United States (Lim et al., 2016), the 
United Kingdom (Doe et al., 2001), and Jamaica (Dunwell & Rose, 2003). The total amount of 
patients that was calculated for the rest of the world was 84,529,077. The count data from the 
United States was calculated from the study by taking the relative frequency and multiplying it 
by the population of the United States. From results of the statistical analysis provided the list of 
the 7 statistically signifcicant diseases that are reviewed in this paper. The top 15 dermatoses 
aforementioned also were placed into 9 categories and the same 2-sample z test for equality of 
proportions for West Africa vs the United States was conducted. Signficant diseases are 
indicated with asterisks*. The top 15 categories belong to categories that include dermatoses 
outside of the sole dematitis itself. This allowed up to see where the categories of the top 15 
dermatoses ranked in overall rate of incidence in West Africa. 
 
A. Distribution of Skin Disease 
In regard to the distribution of the skin disease, the rate of incidence and prevalence was 
reviewed. This lightly touches the epidemiological factors that influence the rates of incidence, 
patient profile, and predisposed populations. 
 
B. Etiology of Disease 
 The etiology of the diseases was included by understanding the original pathogen taxa for 
the skin condition. 
 
C. Pathology 
The pathology and histology of the diseases are reviewed through primary and secondary 
sources to show the microscopic view of tissue in a diseased state. For consistency of data, and 
ease of analysis, the pathology of the skin disease will discuss the cells active and the afflicted 
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location in the derms and epidermis. The prognosis of disease will be closely reviewed by the 
conducting institution. 
 
D. Metrics of Classification of Skin Disease Severity 
When generally reviewing the burden of skin disease, the metrics are most important. 
One specific group of metrics are the years of life lived with disability (YLD) and years of life 
lost (YLL) (Aksut, Dellavalle & Naghavi, 2017). Together these two criteria place each skin 
disease in a tier system. Uncovering a solution to skin disease that affects large populations with 
low YLL versus a solution regarding skin disease involving a smaller number of individuals with 
a high YLL is the resounding question at the end of this global debate. 
Keywords that are used in the electronic database search are noted and will include the 
terms: West Africa, global, skin, disease, dermatoses, epidemiology, pathophysiology, Africa, 
disorder, dermatologic, prevalence, hospital, clinic, cutaneous, conditions, incidence, pattern, 
Nigeria, Ghana, Benin, Cameroon. 
The results of this literature review are visually organized using tables that include the 
disease, population (age, gender, ethnicity) most affected, distribution of occurrence (which 
relates to the specific percentage of people that are receiving this disease in proportion to the 
general population, displayed as a percentage), main epidemiological cause of dermatosis, 
prognosis, pathology, and references.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
 
1. Graphs include Venn diagrams that compares and contrasts the dermatoses between West 
African and the United States, histology and pathology of the statistically significant 
dermatoses, and sample images of the phenotypic manifestation of each skin disease.  
2. The immunopathogenesis in relation to the cytokine profile of the most abundant 
dermatoses are given. 
3. Statistical analysis of the quantity of skin diseases was performed using a meta-analysis 
method of 24 peer-reviewed articles that include the skin diseases aforementioned. For 
occurence of dermatoses in West Africa, the frequency of each skin condition was 
calculated by ICD-9-Dermatological Category and for the cumulative frequency of the 
entire peer-reviewed study. Dermatoses that are categorized under ‘Other’ are excluded 
as their true identity is not revealed to make a significant conclusion on the disease. The 
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data was wrangled from percentages of each study to create count numbers for each skin 
disease. The relative frequency was multiplied by total number of participants for each 
study, to get the total count for that exact dermatosis participant count. After this, the 
dermatoses were sorted through RStudio software by their total counts of patient disease. 
Group totals and individual dermatosis totals were sorted.  
i. After a collection of the top dermatoses through sorting, statistical analysis of 
each of these diseases compared to the US rate of incidence was analyzed using a 
two proportions z test to compare West African Disease counts to the US disease 
counts. Acne Vulgaris in West Africa was categorized as Acne (unspecified) in 
the United States. Localized Vitiligo and Vitiligo in the United States was 
grouped into one category for our statistical analysis. Any diseases without counts 
was considered NULL for R statistical analysis, as this number was not observed. 
P-values of ≤ 0.05 are considered statistically significant. 
 
VI. Results of Literature Review 
The top dermatoses responsible for disability-adjusted life years (DALY) and years lived 
with disability (YLD) worldwide are the following dermatoses: dermatitis,, acne vulgaris, 
urticaria, psoriasis, viral skin diseases, fungal skin diseases, scabies, melanoma, pyoderma, 
cellulitis, keratinocyte carcinoma, decubitis ulcer, alopecia areata, pruritis, with the remaining 
dermatoses falling under the miscellaneous ‘Other skin and subcutaneous diseases’ category 
(Karimkhani et al., 2017) 
 
 
A. Common African Skin Diseases 
The top 15 common skin diseases of West-Africa ranked by count and relative frequency 
are Atopic Dermatitis (RF: 7.49%), Pityriasis (Tinea) Versicolor (RF: 4.94%), Acne Vulgaris 
(RF: 3.73%),  Papular Urticaria (RF: 3.47%), Tinea (unspecified dermatophytosis) (RF: 2.94%), 
Contact Dermatitis (RF: 2.94%), Scabies (RF: 2.76%),  Seborhheic Dermatitis (RF: 2.50%),  
Pityriasis Rosea (RF: 2.26%), Urticaria (2.18%), Human Pappilomavirus / Viral Warts (1.85%), 
Tinea Capitis (RF: 1.80%), Lichen Planus (1.77%), Vitiligo (RF: 1.77%) and Lichen Simplex 
Chronicus (RF: 1.45%). 
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Based on the results of a 2-sample test for equality of proportions with continuity 
correction, there is a statistically significant difference between atopic dermatitis (p < 2.2e-16), 
acne vulgaris (p < 2.2e-16), urticaria (p < 2.2e-16), contact dermatitis (p<2.2e-16), sebhorreic 
dermatitis (p < 2.2e-16), human pappilomavirus (p = 1.708e-6) and vitiligo (p < 2.2e-16) in West 
African individuals vs individuals in the United States. Atopic dermatitis has a higher relative 
proportion in West Africa vs the United States (.0749 and 0.0099, respectively). Acne vulgaris 
has a higher relative proportion in West Africa vs the United States (0.0373 and 0.0163, 
respectively). Urticaria has a higher relative proportion in West Africa vs the United States 
(0.0218 and 0.0072, respectively). Contact dermatitis has a higher relative proportion in West 
Africa vs the United States (0.0294 and 0.0417, respectively). Sebhorreic dermatitis has a higher 
relative proportion in West Africa vs the United States (0.0250 and 0.0135 respectively). Human 
pappilomavirus has a higher relative proportion in West Africa vs the United States (0.0185 and 
0.0153, respectively). Vitiligo has a higher relative proportion in West Africa vs the United 
States (0.0177 and 0.0057, respectively) 
The top categorical dermatoses in of West-Africa ranked by count and relative frequency 
are summarized in Table -----. These are Dermatitis (RF: 22.09%), Fungal Diseases (RF: 
16.53%), Infestation, Bites, and Stings (RF: 7.84%), Viral Diseases (RF: 6.04%),  Acneiform 
(6.03%), Lichenoid and Granulamatous Disorders (RF: 4.49%), Melanocytic Disorders (RF: 
4.08%), Psoriasiform Disorder (RF: 3.90%),  Neutrophilic, Eosinophilic, and Mast Cell 
Disorders (RF: 3.20%). To reiterate, these relative frequency numbers are based on the frequency 
of the disease divided by the total frequency of the patient disease count. 
Based on a 2-sample test for equality of proportions with continuity correction, there is a 
statistically significant difference between categorical classifications of Dermatitis (p < 2.2e-16), 
Psoriasiform Disorder (p < 2.2e-16), Viral Diseases (p < 2.2e-16), Lichenoid and Granulamatous 
Disorders (p<2.2e-16), Melanocytic Disorders (p < 2.2e-16), Neutrophilic, Eosinophilic, and 
Mast Cell Disorders (p = 1.708e-6) and Acneiform (p < 2.2e-16) in West African individuals vs 
individuals in the United States. 
 1. Dermatitis  
Under the inflammatory category of the top 15 ECOWAS dermatoses are the eczemas, 




2. Psoriasiform Disorders  
Psoriasiform disorders include pityriasis rosea as the dermatosis in this category of the 
top ECOWAS dermatoses. 
3. Infestation, Bites, and Stings 
Papular urticaria and scabies are the dermatoses in this category of the top ECOWAS 
dermatoses.. 
4. Fungal Disorders 
Diseases under the infectious fungal classification include tinea capitis and tinea 
(unspecified), pityriasis (tinea) versicolor in this category of the top ECOWAS dermatoses.. 
5. Viral Diseases 
 Human papillomavirus (viral warts) as the dermatosis in this category of the top 
ECOWAS dermatoses.. 
6. Licheoid and Granulamatous Disorders 
Lichen planus is the dermatosis in this category of the top ECOWAS dermatoses.. 
7. Melanocytic Disorders 
Melanocytic disorders also include pigmentary disorders such as vitiligo as the 
dermatosis in this category of the top ECOWAS dermatoses.. 
8. Neutrophilic, Eosinophilic, and Mast Cell Disorders 
Urticaria is the dermatosis in this category of the top ECOWAS dermatoses. 
9. Acneiform Disorders 
Acneiform Disorders include acne vulgaris as the dermatosis in this category of the top 





Table 2: This table demonstrates the rates of prevalence of the top 15 dermatoses in both 
West Africa and the United States. 
 
  
Disease # of West African 
Occurrence 
# of United States 
Atopic Dermatitis* 2601 836790 
Pityriasis (Tinea) Versicolor) 1716 NULL 
Acne Vulgaris * 1296 1377744 
Papular Urticaria 1205 NULL 
Tinea (Unspecified) 1089 NULL 
Contact Dermatitis * 1021 3524659 
Scabies 957 NULL 
Sebhorreic Dermatitis * 866 1141077 
Urticaria* 756 608574 
Pityriasis Rosea 786 NULL 
Human Pappillomavirus * 641 1293220 
Tinea Capitis 624 NULL 
Lichen Planus 616 NULL 
Vitiligo * 616 482071 
Lichen Simplex Chronicus 504 NULL 
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Table 3: The relative frequencies of the ECOWAS dermatoses and the their US RF counterparts. 






Atopic Dermatitis* 7.49% 0.99% 
Pityriasis (Tinea) Versicolor) 4.94% 0.00% 
Acne Vulgaris * 3.73% 1.63% 
Papular Urticaria 3.47% 0.00% 
Tinea (Unspecified) 2.94% 0.00% 
Contact Dermatitis * 2.94% 4.17% 
Scabies 2.76% 0.00% 
Sebhorreic Dermatitis * 2.50% 1.35% 
Urticaria 2.18% 0.72% 
Pityriasis Rosea 2.26% 0.00% 
Human Pappillomavirus * 1.85% 1.53% 
Tinea Capitis 1.80% 0.00% 
Lichen Planus 1.77% 0.00% 
Vitiligo * 1.77% 0.57% 





Figure C:  The performed 2-sample z test comparing the relative frequencies (RF)of the top 15 
dermatoses in ECOWAS in comparison to the RF in the United States. Statisticaly significant 

































Table 4: The dermatoses categorical classification based on Fitzpatrick Dermatology (Kang et 
al., 2019) disease categorization. The second column accounts for the number of dermatoses 
from the top 15 ECOWAS diseases that belong in the corresponding categories. These 
categrories are the only groups selected for statistical analyisis against their corresponding 
groups in the US. The average categorical disease frequency is calculated in the third column and 















Dermatitis 4 7768 22.09% 6.51% 
Psoriasiform 
Disorder 1 1355 3.90% 0.51% 
Infestation, Bites, 
and Stings 2 2722 7.84% 0.00% 
Fungal Diseases 3 5737 16.53% 0.00% 
Viral Diseases 1 2095 6.04% 7.28% 
Lichenoid and 
Granulamatous 
Disorders 1 1558 4.49% 0.96% 
Melanocytic 
Disorders 1 1415 4.08% 0.57% 
Neutrophilic, 
Eosinophilic, and 
Mast Cell Disorders 1 1111 3.20% 0.72% 





Figure D: The performed 2-sample test comparing the relative frequencies (RF) of the 
categorical top 15 dermatoses in WA in comparison to the relative United States. Statisticaly 
significant diseases in comparison to the United States RF are indicated with (*). 
 
B. Common West African Skin Diseases 
1. Atopic Dermatitis (Acute, Subacute, Chronic) 
Incidence & Prevalence (Frequency):  
The inflammatory disesase atopic dermatitis is diagnosed through the pruritic rashes that 
plague the patient’s skin. Of those mostly affected by this condition, children unfortunately 
commonly fall ill to this disease. The age of onset is roughly one to twelve years old. It is at this 
age where over 60% of the affected patients will have their atopic dermatitis resolve itself 
(Odhiambo, 2009). Although common to the general public, this form of dermatitis occurs 
frequently in those genetically predisposed and animal caregivers (Katsarou & Armenaka, 2011). 
Lifestyle plays a significant role in the acquisition and exacerbation of this disease. Lifestyles of 
taking hard, hot showers can accelerate the production of scales on the face, cheek, ands legs for 





























dermatitis, there comes a 50% possibility or more of an offspring having the condition as well 
(Barnes, 2010).  
 
Etiology 
The etiology of atopic dermatitis is uknown however there are genetic and environmental 
components to it. One bacterial organism responsible for example, is the bacteria 
staphyloccoccus aureus. The S.aureus species is a commensal and pathogenic bacteria is apart of 
an indoviduals skin microbiome, or skinome. A collective study showed that infants aged as 
young as three months, afflicted with atopic dermatitis, show a significant increase in S. aureus 
as compared to their non-affected age-mate counterparts (Meylan et al., 2017).  
 
Risk Factor (race, sex, age) 
As aforementioned, roughly 60% of atopic dermatitis cases onset at the age of a few 
months to 12 years old. If one parent has atopic dermatits, the poassibility of the child bearing 
the disease is well over 50%. Hot, hard showers give rise to the puriritic scales on the skin in 
addition to the socioeconomic and lifestyle factors such as tress, smoking, exposure to dander 




From an immunological standpoint, atopic dermatitis is a TH2-acute immune response 
regulated by the cytokines IL-17, IL-23. This then gives the downstream release of cytokines 
IL4, IL-5, IL-13, which downregulate AMP production, thus creating an overactive immune 
response, which phenotypically manifests as upregulated inflammation and itching (Howell et 
al., 2008). On the other hand, chronic atopic dermatitis, is driven through a TH1-actute immune 
response with release of cytokines IL-12 and IFN-γ (Yamanaka & Mizutani, 2011). During the 
atopic dermatitis response, the filament-aggregating protein, fillagrin, is broken down and loses 
function with transepidermal water loss. This dermatitis is deficient in ceramides (and 
sphingolipids) together in the stratum corneum which leads to poor skin barrier (Danso et al., 





IL-4 is a regulatory cytokine in this condition that activates the TH2 cells which then 
release IL-5 to activate eosinophils, IL-13 and upregulation of IgE production. These cytokines 
generated help downregulate TLR levels thus lowering AMPs and reducing the amount of lipids 
in the stratum corneum (Noda, Krueger, & Guttman-Yassky, 2015). This gives reason as to why 
you will see atopic dermatitis with fewer antimicrobial peptides while psoriasis has little to no 
staphyloccocus bacteria with upregulation of AMPs (Howell et al., 2008).  
During atopic dermatitis, the immunological factors also affect the skin microbial 
compositions. AMPs have an important role in preventing pathogenic microbes from infecting 
the skin (Kwiecien et al., 2019). The two main classes of AMPS in the skin are cathelicidin and 
beta-defensins (DEFBs) which are able to destory S.aureus in vitro. When you compare levels of 
cathelicidin and DEFB-2 and 3 in psoriasis, there is a significant decrease in these AMPs when 
compared with psoriatic skin. The other IL-10 cytokine from TH2 cells are also shown to have 
decreased expression in AMPs (Kim et al., 2016). More recently, cytokines IL-17, IL-18, IL-31 
have been recently discovered to be upregulated in atopic dermatitis lesional skin (Kim et al., 
2016). 
 
S. aureus in AD disease 
In relation to AMPs, the overgrowth of S.aureus will be synonymous with a decrease of  
AMPs in atopic dermatitis lesions. The correlation between TLR-2 and cathelicidin AMP reflects 
an increase in both levels of proteins (Schmid, Andreas et al., 2017). There are virulence factors 
secreted by S.aureus which is the superantigen factor. This superantigen  that α-toxin is known to 
increase the severity of atopic dermatitis through inducing cell lysis and being toxic to 
keratinocytes while also stimulating IgE responses. Upregulated levels of TH2 cytokines lower 
the fillaggrin expression and sphingomyelinase, inducing the continuous cycle of keratinocyte 
susceptibility to that α-toxin. This results in the poor barrier function and permeation of irritants 
and various allergens in atopic dermatitis (Dou et al., 2019). 
This results in excessive production of T cell cytokines which causes cytotoxicity. SAgs 
are also allergens and stimulate an Immunoglobulin-E (IgE) response. Another factor is α-toxin 
that has been proposed to increase AD severity. The α-toxin monomers form a heterodimer 
complex on the cell membrane that creates a porous channel leading to cell lysis. It has been 
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shown that α-toxin is severely toxic to keratinocytes. In AD, high levels of Th2 cytokines reduce 
expressions of filaggrin and sphingomyelinase, making keratinocytes more susceptible to α-
toxin. This can result in loss of barrier function, increase in penetration of irritants and allergens 
and development of AD (Dou et al., 2019). 
 
Gut Microbiome in AD 
Through the use of probiotics, the gut mirobiome can regulate the immunologic pathway 
in atopic dermatitis. These probiotics are taken orally and interact with the GI mucosa and gut-
associated lymphoid tissue (GALT) that house over 70% of the immune cell inventory. These 
probiotics interact with macrophages, DCs of the mucosa and epithelial cells in multiple ways. 
Depending on the strain of bacteria, the probiotic can produce IL-12, IL-18, and TNF-α, or or 
have anti-inflammatory effects on the environment through releasing cytokines, IL-10 and TGF-
β. These anti-inflammatory cytokines are fundamental in inducing immune tolerance in the skin 




















Pathology  (Microscopic View *Images) (Gross & microscopic) 
Gross 
 
Atopic dermatitis in an AA teenager showing  scaly, lichenified, and dyspigmented areas of the 





Hyperkeratotic cap in the stratum corneum stationed above the acrosyringium in the stratum 
spinosum of atopic dermatitis. (Miteva et al., 2017) 
 
2. Acne (Vulgaris) 
Incidence & Prevalence  
Most of acne affects about all people from ages of 15-17 years and about 15-20% of all 
young people and 85% of people from ages (Law et al., 2010). The rates of prevalence was 
roughly about 40-50 million from a 1996 census survey. Luckey et al.’s study shown that the 
severity of acne in regard to puberty where half of the 10-11 year old boys had 10+ comedones 
(White, 1998). These comedones are one of the primary clinical diagnoses of acne vulgaris, 
including papules, pustules, nodules and cysts (Taylor et al., 2011). The team also noticed that 
78% of girls between 8-12 years were afflicted with acne. The severity of the acne was shown to 
increase by progression of maturation in pre-pubescent young women. For young women, the 
levels were upregulated (Lucky et al., 1997). For the top three prevalent skin diseases, acne 
reigns as one of the top dermatoses. In the United States, United Kingdmom, France acne is one 
of the top dermatoses and now acne is also amongst the top dermatoses with the 2nd top skin 
disease. The  levels were seen to be upregulated in these young women. Amongst the top three 
prevalent dermatoses, acne was identifed as one of the top three skin condition in the UK (Rea, 
Newhouse, Halil, 1976), France (Wolkenstein et al., 2003), and USA (Johnson & Roberts, 1978), 
and here, we see that acne is the same for West Africa. In West African skin, which is also skin 
of color, acne is primarily inflammatory (Dreno et al., 2015). 
Etiology 
Gram-positive P. acnes is normally found on the milieu of the pilosebaceous canal and 
mostly located in sebaceous areas and found on the skin. The bacterium’s involvement is not as 
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clear as the understanding that P. acnes is not a pathogen for acne, if it were a traditional 
infectious disease. There are mainly four pathways that provide P. acnes the adequate 
inflammatory pathways in inflammatory acne. TLRs, inflammasome activation, MMP 
production, and antimicrobial peptides being stimulated. There are also different effects on the 
innate immune from different P. acnes strains but the adaptive immune system can be activated 
through the complement system and attack neutrophils via the C5 mechanism (Dreno et al., 
2015). 
Furthermore, with Th17 cells and P.acnes, there is an IL-17 response from the activated 
CD4 T cells, exerted by the anaerobic lipid-rich environment of the sebaceous follicles. As IL-17 
is prevalent in acne lesions. Futher studies should examine the immunological profile of acne in 
patients with skin of color, and those of the West African  populations/diaspora both clinically 
and epidemiologically. Additionally, the different phylotypes of P.acnes correlate to various 
pathogenic associations with non-inflammatory (comedones) vs inflammatory acne lesions. 
Studies found that this genomic variation of the phylotype IA shows an increase in inflammatory 
lesions, while the and phylotype IB Type II are decreased ((Nelson & Schneider, 2016). 
Milk, dairy and fats are associated with the insulin-like growth factor binding protein and 
IGF-1 which connects the nutrient availability to mTORC signaling pathways in acne 
pathogenesis. The mechanisms of how food is a risk factor of acne vulgaris. The involvement of 
the insulin/IGF-1 signaling pathway demonstrates a process of food-induced activation. This 
activation of the axis triggers acnegenic effects that related to lipogenesis of the sebaceous 
glands. Milk products contain IGF-1 in addition to other the high-GI foods, fats, meat and dairy 
proteins that increase the levels of insulin and IGF-1. These levels of insuling and IGF-1 supply 
the mammalian target of rapamycin complex-1 (mTORC-1) and forkhead box O1 signaling 
pathways with nutrients to the acne-pathogeneis signaling processes (Norat, Dossus, & Rinaldi, 
2007).  
The pathogenesis has been controversial since the early 1900s. Studies have shown that 
the glycaemic index (GI), diet and prevalence of acne has been inconclusive. More recent 
research has shown that the emphasis of the mechanisms of high GI foods are correlated with 
lesional acne pathogenesis. A specific study focused on 32 acne-prone patients that are filled 
with a diet of carbohydrates and review of the course of 10 weeks. There was a 70.9% decrease 
of inflammatory lesion count in comparison to the baseline and smaller sebaceous gland size in 
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the lower GI diet group (Kaymak et al., 2007). From these studies, it is conclusive that there is 
lower activity and subsidized sebum production in acne vulgaris. 
 
Risk Factors 
In regards to the risk factors of acne,  there is an axis between diet, genetics, and P.acnes. 
A 4-month case study reflects that people with acne and a higher GI diet consumed larger 
amounts of milk and ice cream compared with controls (Ismail, Manaf & Azizan, 2012). The 
amount of milk consumed related to acne is 3 or more servings of milk per week, but the amount 
is not identified for skim milk (Ismail, Manaf & Azizan, 2012), which is shown to have a higher 
correlation with acne (vulgaris) with a higher GI of 4 vs 3 (Foster-Powell, Holt, Brand-Miller, 
2002). The dairy powerhouse, chocolate, shows that daily consumption of 50 g for four induced 
the release of the cytokine IL1β and IL‐10 to further stimulate the P.acnes bacterium. 
 There are other theories that provied further explanation for the risk factors by way of a 
high GI diet. These theories provide way to give reason as to why indigenous populations of 
Papau, New Guinea have no acne in comparison to a Westernized diet and lifestyle such as in 
Belgim with prevalent acne (Cordain et al., 2002). 
 A genome-wide association study (GWAS) of European American teenagers with severe 
acne was conducted using the Nurses’ Health Study II cohort. The chromosomal locus of 8q24 
was found to be associated with severe acne amongst teenagers. As this locus has previous ties to 
prostate, breast, ovarian, colon and bladder cancers, and these ties can be correlated to is close 
proximity of the proto-oncogene Myc in addition to androgren receptor genes. The main qualm 
with this study surrounds the self-reported data collected with no objective assessments of acne 
(Zhang et al., 2014).  
 An additonal study discussed polymorphisms in cutaneous androgren genes which 
regulate genes HSD3B1 and HSD17B3 with increased susceptibility to developing acne vulgaris 
in this population. Comparatve genomic analysis of 82 P.acnes phylotypes which were isolates 
of the two levels of subject variables. The study concludes that phylotypes from the same 
individual are closely related to one another rather than related to phylotypes from different 
individuals (Yang et al., 2013). This is indicative of clonal expansion in the microbiomes’ of 
participants. This may provide, after understanding the genetic compartents of P.acnes, 
comprehension of the difference between commensal bacteria in acne and in non acne skin. 
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Another study from the authors includes metagenetic analyses of P.acnes from 49 and 52 people 
with and without acne, which gave way to the discovery of P.acnes structures as they were 
different between the two groups in terms of key markers. This structural understanding provides 
insight as to how acne may vary between individuals. The genomic achievements of the human 
P.acnes genome has been incredibly useful in the development of molecular-based therapies, a 
fairly de novo area of acne treatments (Fitz-Gibbon et al., 2002) treatment. 
 
Pathogenesis 
Acne pathogenesis is known by hyperproliferation and abnormal differentiation of the 
follicles of the epithelium. It includes excess sebum production, proliferation of P.acnes in 
addition to formation. The inflammation that presents itself in lesional acne and microdomes. 
Immunohistochemical studies show higher levels of CD4 cells, macrophages and IL-1- alpha for 
patients with acne compared with skin of those without acne. These findings elucidate the idea 
that inflammation comes before hyperproliferation (Ingham et al., 1992). All acne is 
inflammatory. Studies have shown that higher doses of IGF-1 will develop acne as IGF-1 
replacement therapy leads to acne and hyperandrogenism. There are multiple mechanisms of 
IGF-1 that lead to and induction of androgen synthesis, and activate the FoxO1 that allows for 
further androgen synthesis. This then increases the sebum triglycerides and fatty acid 
desaturation which led to more inflammation and comedogenic fatty acid profiles (Abulnaja, 
2009).  
Changes in the diet allow for sebum quantity to change and promote P.acnes overgrowth 
and gives room for the formation of biofilm. The P.acnes bacterium allows for the triglyceride 
lipase to increase palmitic and oleic acids levels, which lead to biofilm formation. The palmitic 
acid and P.acnes molecular patterns activte TLR2 and stimulates IL-1-beta signaling and 
inflammasome activation (Kim, 2002). The oleic acid allows for proliferation of keratinocytes, 
adhesion of the P.acnes bacterium, and IL-1-alpha release and formation comedones. Different 
phylotypes of P.acne have different phenotypes. P.acnes associated with acne induce high levels 
of IFN-γ and IL-17 in blood cells  than those with non-afflicted skin. Healthy skin induces higher 
levels of IL-10, indicative of anti-inflammatory mechanisms at play in non-afflicated skin 
(McLaughin, 2019).  
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The key player in the innate system’s role on the proinflammatory pathways. It activates 
TLR2 for monocytes and provides the release of IL-12 and IL-8. The cytokines IL-1 beat and IL-
8 are secreted through the caspase-1 and nucleotide oligomerization domain-like receptor protein 
(NLRP) (Dreno et al., 2015) that . In regards to P.acnes, stimulates the adaptive systems through 
inducing the IL-17A and IFN-γ secretion from CD4+ T cells in vitro. TH17 cells and TH1 cells 
can react to the stimulation of P.acnes in patient cells that have a strong response to P.acnes 
(Kelhälä et al., 2014).  
 Propionibacterium acnes does activate TLR-2, TLR-4 on inflammatory cell membranes. 
The cytokines released are TNF-a, IL-1, IL-6, IL-8 and IL-12. The more severe acne is, the more 
cells will express TLR-2.  This gives way to the cytokines that are created in proportion to 
P.acnes and it’s interactions with TLR-2, defensins and MMPs (Dreno et al., 2015). 
Milk, dairy and fats are associated with the insulin-like growth factor binding protein and 
IGF-1 which connects the nutrient availability to mTORC signaling pathways in acne 
pathogenesis. The mechanisms of how food is a risk factor of acne vulgaris. The involvement of 
the insulin/IGF-1 signaling pathway demonstrates a process of food-induced activation. This 
activation of the axis triggers acnegenic effects that related to lipogenesis of the sebaceous 
glands. Milk products contain IGF-1 in addition to other the high-GI foods, fats, meat and dairy 
proteins that increase the levels of insulin and IGF-1. These levels of insuling and IGF-1 supply 
the mammalian target of rapamycin complex-1 (mTORC-1) and forkhead box O1 signaling 
pathways with nutrients to the acne-pathogeneis signaling processes (Norat, Dossus, & Rinaldi, 





Pathology (Gross & microscopic) 
Gross 
 
Acne vulgaris in AA patient with post-inflammatory hyperpigmentation with pustules and 




Suppurative folliculitis that may be seen in any acneiform disorder such as with acne vulgaris. 
B,C show neutrophils surround and infiltrate the follicular epithelium, usually in large numbers 
typically present in large num- bers within the follicular canal. (Busam, 2010) 
 
3. Urticaria 
Incidence & Prevalence  
The lifetime rate of incidence and prevalence for urtcaria ranges from <1% to 24% based 
on location, age, and sampling methodology (Anita et al., 2018). For women, acute and chronic 
urticaria is more common. For men, the ratio of urticaria compared to women is roughly about 
1:2 (Sánchez-Borges, Capriles-Hulett, Caballero-Fonseca, 2015). For the eldery and young 
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children, the difference compared to women is less understood. In Europe, the lifetime 
prevalence ranges from 0.1% to 0.6% and chronic urticaria can progress in 20-45% of persons 
with initial acute urticaria.  Studies have shown that for Americans, the period of prevalence for 
chronic urticaria was 0.08% while in Europe, data shows a prevalence range from 0.38% to 
0.8%. For regular urticaria, the rate of incidence is lower (Lapi et al., 2016). For physical 
urticaria, the most common type is symptomatic demographism at 40%-73%, and the other solar 
and heat urticaria and angioedema tends to be a tad rarer. Beteween the ages of 25 and 55 years, 
the most common urticaria is chronic urticaria that tends to be there <2 years, and under 20% of 
the patients will have symptoms that last more than 10 years (Amsler, Soria, Vial-Dupuy, 2014). 
Patients with physical urticaria have a longer disease duration as 16% of patients had less than 1 
year of symptoms. In general, urticaria is more popular in adults than in children. The prevalence 
amongst children is about 3.4% to 5.4% and for acute urticaria is from 2 to 73 per 100,000 
emergency room referrals. As for chronic urticaria, the prevalence for children is 0;1% to 0.3% 
in the United Kingdom (Ferrante et al., 2015). As reported for West Africa, we calculated a 
signficant relative frequency of of 2.18% amongst the demographics tested over the course of the 
20 years. 
Etiology 
There are a vast variety of causes of Urticaria that coincide with the type of clinical 
urticaria. As the dermatosis is primarily characterized by activation of effector mast cells and 
their rapid release of histamine, leukotrienes and prostaglandins. Medications such as penicillin, 
aspiring, NSAIDs, sulfonamides, oral contraceptives are a few on this developing list (Kayiran & 
Akdeniz, 2019). Foods such as nuts eggs, seafood, milk, fruits and vegetables can usually cause 
this condition in children (Rajan, Simon, & Bosso, 2014). Respiratiory allergens (pollen, mold 
spores, mites, hair and animal dandruff) (Chow, 2012), infections infections including 
parasitoses, contact urticarial (latex, cosmetics, and chemicals), insect bites, and psychogenic 
factors (stress and depression) can exacerbate the preexisting urticarial and induce further 
urticarial (Bülbül, 2015). Systemic diseases such as thyroid, rheumatic diseases, and carcinomas 
need to be monitored as deemed necessary in these afflicted patients. Pressure, heat, cold, and 
dermographism can manifest urticaria in less than 3-4 hours (Aktan, 2015). Urticaria can be 
hereditary as it is seen in agiodema and familial cold urticarial. Lastly, idiopathic urticarial can 





Acute urticaria is associated with a significantly higher risk of comorbidity with allergic 
diseases such as asthma and atopic dermatitis as well as a family history of allergic disease 
(Kjaer et al., 2008). Overall, patients with urticaria may fall ill commonly due to infection, food 
allergies, drugs, environmental changes and psychological factors. The chronic aspect of chronic 
urticaria is due to consistent triggering due to a specific stimulus aforementioned (Anita et al., 
2018). 
Upper respiratory stands firm as the main common cause of 40% of acute urticaria, drug 
reactions at 9.2%, and potential food intolerance at a low 0.9%. However, for the infectious 
agents, Mycoplasma pneumonia, parasitic infections and other upper respiratory tract organisms 
are more freqeuntly reported in children (Wedi et al., 2009). As for adults, viral helpatitisand 




The main cells involved in the pathogeneis of urticaria are mast cells and basophils 
(Borriello, Granata, & Marone, 2014) and their released mediators. These cell’s activation can be 
caused by immunologic or non-immunologic factors. Mast cells and the basophils are the main 
cells involved in lesional urticaria driven by an IgE immediate hypersensitivity reaction. On the 
other hand, chronic urticaria shows about 30% of cases being associated with IgG antibodies and 
their iffinity to IgE receptors or IgA The vasodialator, histamine is released during degranulation 
during urticarial activity. Further activity of the disease includes increased levels of C-reactive 
protein, IL-6, IL-6 receptor, and MMP-9 (Dilek et al., 2016). The IL-6 medicated processes have 
an impact on the patient’s sleep which are correlated to the severity of night symptoms of 
urticaria as concentrations of IL-6 and it’s soluble receptor are upregulated during sleep 
(Kasperska-Zajac, Grzanka, & Damasiewicz-Bodzek, 2015). 
In relation to modulating the activation of mast cells, reactive oxgen species (ROS) are 
another apparent cause of mast cell degranulation in addition to cell signaling which helps the 
exocytosis of granules from mast cells. Of the complement system, the proteins C3a, C4a, and 
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C5a land on mast cells to help release histamines and function as anaphylatoxins (Ferrer, 
Nakazawa, 1999).  
Adipokines can also impact immune responses in chronic urticaria The protiein lipocalin 
2 and urticaria activity are negatively associated with one another, thus indicating 
antiflammatory properties of the adipokine in CU (Trinh, 2016). In all, these discoveries give a 
full image of the immunopathogenesis of urticaria with histamine release and mast cell activation 
at the foundation.  
 
Pathology (Gross & microscopic) 
Gross 
 
Chronic idiopathic urticaria wheals demonstrating superficial skin swelling surrounded by 












General urticaria with mild dermal edema (A) and margination of neutrophils (B) within post-
capillary venules in acute urticarial. In later stages, a mixed inflammatory infiltrate of 
neutrophils, (perivascular) lymphocytes, and eosinophils are seen (A) (Miteva et al., 2017).  
 
 
Neutrophilic Urticaria with mild edema in the dermis (A) and neutrophils rampage through the 





Urticarial Vasculitis showing eosinophil infiltrates amongst nuclear dust (A) in the dermis as 
well as dermal and endothelial edema (B). (Miteva et al., 2017) 
 
4. Contact Dermatitis 
Incidence & Prevalence [Population Most Affected] 
There are two major subtypes that commonly are seen in patients, irritant contact 
dermatitis (ICD) and allergic contact dermatitis (ACD). ICD is a nonspecific reaction on the skin 
due to a single instance or a repetitive exposure to a substance in contrast to ACD that is an 
immunologic response to antigens upon contact while being categorized as a delayed 
hypersensitivity reaction (Litchman, Nair, Atwater, 2019). There is no specific age as where 
contact dermatitis will occur. The prevalence estimates range from 1.7% to 6.3% in a variety of 
published studies. In West African skin disease we reiterate a significant relative frequency of 
2.94%. As many of our studies do not differentiate between urban and rural areas and gender, 
CD is more common in urban locations while being frequently seen in women and the eldery 
(Statescu et al., 2011). 
 
Etiology 
There are a plethora of substances that can cause irritant dermatitis, on the contrary, it is 
the concentration and the duration of contact of the agent at hand that can determine the chances 
of irritant contact dermatitis. The cause of contact dermatitis is formed by contact allergens or 
irritant substance. It is characterized by the eczematous eruptions that are at the start of a 
multitude of dermatologic conditions (Hamstra et al., 2015). Common causes of irritant contact 
dermatitis include solvents such as xylene and alcohol, rubber gloves sodium lauryl sulfate 
(commonly seen in shampoos), metal working fluids, alkalies, hydrofluoric acid, and even 
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plants! Not only can harsh irritants be the cause of this condition, a repeated exposure to mild 
irritants, such as water and cleansing gels, can initiate a form of ICD known as cumulative ICD 
(Karono & Maibah, 2019). The main allergens in allergic contact dermatitis are nickel, which 
binds to TLR-4, cobalt, fragrance mix, thiomersal, neomycin, and formaldehyde (Schmidt et al., 
2010). The dust mite allergens Der p 2 and Der f 2 are homologs of the protein MD2 that binds 
to TLR-4 in ACD. These dermatophagoides subspecies consume keratinocytes and can be found 
on clothing, bedding and the skin (Shane, Long, Anderson, 2019). 
 
Risk Factors 
Although we do see women and the elderly as frequent victims of CD, age and sex alone 
cannot determine complete risk factors for this eczematous dermatosis. The occupational and 
home activities that frequent women and the elderly’s daily lives can give rise to the higher rates 
of incidence (Statescu et al., 2011). Occupations are the number one risk factprs of acquiring CD 
as a whopping 80% of these skin conditions amongst occupations are irritant contact dermatitis. 
Susceptible populations include those with an atopic diasthesis in contact dermatitis (Litchman, 
Nair, & Atwater, 2019). There are, of course, environmental factors of dry air amongst high 
temperatures as seen in climates closer to the equator and warmer summer seasons. These factors 
can increase the potency effect of the contact agent. 
 
Pathogenesis 
Allergen-to-skin contact initiates the pathogenesis of ACD. This allergen passes through 
the stratum corneum where Langerhan cells migrate upward to local lymph nodes, and allergens 
present themselves to T cells. This is denoted as the ‘sensitization’ phase. These T cells then 
generate various cytokines such as IFN-γ that induce the inflammatory storm aforemention. It is 
important to not that only patients whom have been previously been sensititzed and produced 
specific T cells to the allergen can develop ACD (Richard and Harris, 2014). 
Allergy is the phenomenon known to ilicit a hyperactive immune response to an allergen. 
Allergic contact dermatitis occurs after immediate exposure to chemical or nuance environment. 
This mainly results in the production of neoantigens due to haptenization and generating 
modified-self immunogenic antigens (reviewed by Kaplan et al. 2012). These haptens induce 
oxidative stress in keratinocytes by releasing reactive oxygen species and ATP that speeds up the 
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sensitization process. These immunogenic antigens can even be byproducts of the degredation of 
hyaluronic acid and active the important TLRs and producing proinfllammatory cytokines by 
tissue resident immune cells. Research shows that TLR-2 and/or TLR-4 in IL-12 
dependent/independent pathways mediates the recognition of these neoantigens. The repeated 
exposure to the allergen induces the consistent type IV hypersensitivity reaction and 
sensitization. This is depicted by a large influx of T cells to the epidermis which induces 
detrimental tissue damage and an inflammatory storm (Richard and Harris, 2014). 
The dust mites cause allergic responses that induce IgG and IgE responses for 
hypersensitivity reactions regardless of the immunity these antibodies provide. The 
dermal/epidermal resident mast cells will degranulate after they are bombarded with surface-IgE 
upon encountering an allergen. Avoidance of contact with the allergen is the preferred form of 
treatment (Richard and Harris, 2014). 
Irritant contact dermatitis involes impairment of the skin’s barrier, changes in the 
epidermal cells and proinflammatory cytokine release such as IL-1α, IL-1β, TNF-α, IL-6, and 
IL-8. Keratinocytes release these mediators as a reaction to the chemical stimuli from the 
irritants, thus reigning as  primary pathogenic factors for ICD. There is no need for prior 

















Pathology (Gross & microscopic) 
Gross 
 
Allergic Contact Dermatitis (ACD) in AA child due to nickel in a metal button on denim jeans. 
Black patients normally contract ACD from contactants such as PPD, nickel, chromates, and 
mercaptoben- zothiazole. As seen above, this dermatitis is often complicated by hyper- 
pigmentation and lichenification unless treated early and vigorously with systemic 
corticosteroids. (Taylor et al., 2011) 
 
 
Irritant contact Dermatitis and photoallergic contact dermatitis show eosinophilic spongiosis in 
the epidermal layer of the skin. (Miteva et al., 2017) 
 
5. Seborrheic Dermatitis 
Incidence & Prevalence 
For immunocompetent adults, sseborrheic dermatitis (SD) has a prevalence and incidence 
rate of 1% - 3% of the population while being more common in men than in women (Gupta & 
Bluhm, 2004). As for infants, SD occurs normally within the first three months for this 
population, in addition to occuring in adolescents and young adults. The rate of incidence grows 
further for patients over the age of 50 (Rosso, 2009). A previous cross-sectional case studies 
have evaluated over 2,035 patients in Greece and showed a total prevalence of 4.05%. A 
pediatric study in that same country showed that Greek children aged 0 to 15 years had a lower 
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relative prevalence  (2.5%) than in Indian (11.3%), Chinese (3.2%) children (Sardana et al., 
2009). For this rate was 4.05% yet lower than British and Chinese populations at 2.35% and 7%, 
respecctively (Goh & Akarapanth, 1994). The relative rate of incidence for West Africa is 2.50% 
and comparatively is higher than the Chinese adult population aforementioned. 
 
Etiology 
As there is not a definite image of the etiology of SD, the speculation surrounds 
Malassezia furfur as the organism of selection. This saprophytic fungus is the main cause of 
Tinea versicolor, a common dermatosis caused by an infection of the skin that leads to changes 
in pigmentation of the trunk and upper arms. SD has a multitude of etiological layers that include 
endogenous and exogenous factors for the development. Due to the knowledge that men do 
encounter SD more often, outside of infants, this develops mainly during the onset of puberty. 
This is suggestive of there being a hormanal component of the etiology of the disease, due to 
androgens. At this pubescent age, sebaceous glands are most active, providing reason as to why 
the lesions in SD are frequented in sebaceous gland-dense areas (Schwartz, Janusz, & Janniger, 
2006).   
Furthermore, a Malassezia infection has a pathogenic role in SD due to the positive 
correlation between yeast population density and SD severity of the skin. This theory s further 
supported by the highly effective antifungal therapy in SD (Gupta & Bluhm, 2004).  
 
Risk Factors 
Immunocomopromised and immunosuppresed patients such as orgran transplants 
recipients, HIV/AIDS patients, patients afflicted with the hepatitis C virus, and other 
immunosuppressive ailments (Lally et al., 2010). This population’s rate of incidence being a 
floundering rate of 83% in comparison with the vastly lower 1%-3% rates of the general public, 
which indicates the importance of immunity in the pathogenesis of this disease (Faergemann et 
al., 2001). SD is also more common amongst patients with neurologic and psychiatric diseases,  
such as Parkinson’s disease and mood depression as well as patients with genetic disorders such 





The humoral and cellular immunity has had a bit of contradictory results, where one 
study (Keiffer et al., 1990) found a low-level of the CD4+/CD8+ cell ratio in 68% of patients 
versus a study where another study (Ashbee et al., 1994) found a regular, standard ratio in all the 
patients with SD. An additional study discovered that there were normal levels of CD4+/CD8+ 
cells but a lower number in roughtly 28% of patients with an increase of natural killer cells in 
48% of patients. The varying increased and decreased levels of the immune cell population 
indicate battered cellular immunity. The adjsted CD8 T cell counts have reflected a cytokine 
release (Faergemann et al., 2001). The Malassezia yeast lowers the production of pro-
inflammatory cytokines that relates to the presence of the microfibrillar layer around yeast cells. 
This high amount of lipids extracted amongst the cell walls been demonstrated in studies to 
reverse the capacity of reduction of pro-inflammatory cytokines thus preventing the induction of 
inflammation (Kesavan, Holland & Ingham, 2000). In SD, this yeast does too fall short of having 
a consistent lipid layer and gives potential reason to the inflammation in the disease (Prohic, 
2009). The Malassezin and indole-3-carbaldehyde are ligands that have implications in 
immunologic occurences such as the differentiation of TH17 cells which were only produced on 


















Pathology (Gross & microscopic) 
Gross 
 
Sebhorreic Dermatitis usually has ill-defined greasy soft scale involving the scalp, and nasolabial 
and retroauricular skin folds. The picture shows aforementioned hypopigmented and scaley 




Seborrheic dermatitis seldom requires biopsy. In photo A, seborrheic dermatits of the scalp 
demonstrating shoulder parakeratosis with serum crust in the stratum corneum. Note the 
acanthosis in the spinous layer B. Pityrosoporum of the parakeratotic layer of SD (yeast as the 
‘spaghetti’ fibers and spores). (Miteva et al., 2017) 
 
6. Human Papillomavirus (Viral Warts) 
Incidence & Prevalence  
In the US, there are roughly 14 million new human papillomavirus (HPV) infections with 
about 79 million individuals currently infected (CDC, 2020). The spread of HPV occurs through 
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skin-to-skin sexual activity and is prevalent in all populations that are sexually active. The CDC 
estimated that at least half of all sexually active individuals will contract HPV at some point, and 
at least 80% of women will acquire the HPV infection by the age of 50 (CDC, 2004). In the US, 
roughtly 10% of the population is estimated to have active HPV infections, 4% has the infection 
that caused cytological abnormalities and 1% has an infection that is the source of genital warts 
(Koutsky, 1997). The calculated rate of relative prevalence for West African HPV is 1.85%. 
There are oncogenic HPV strains (commonly strains 16, 18, 31, 33, 35, 39, 45, 51, 52, 
and 58) associated with anal, cervical, vaginal, and vulvar cancers, in addtion to non-oncogenic 
and low-risk cancers (6, 11, 40, 42, 43, 44, and 54) which are associated with genital warts 
(Muñoz et al., 2003). The most common and oncogenic type is HPV 16 with an infection rate of 
10.4% and for HPV 18 with an infection rate of 4.1% for the same 2-year period (Brown et al., 
2005). Studies have shown that women who have sex with women are not immune to HPV as 
their DNA has been found in both low-risk and high-risk HPV (Marrazzo et al., 2001). HPV 16 
is notable connected to over 50% of cervical cancers (Stone et al., 2002), so understanding this 
form of HPV is of preferred focus. A study reviewed the HPV 16 antibodies that demonstrate 
prior exposure to HPV rather than the viral DNA load from frequent tests, and found that women 
were more likely to be seropositive for HPV 16 (17.9%) than men (7.9%). Au contraire, the 
method slightly undermines the prior exposure to HPV 16 as <60% of women with HPV 16 
devlop the specific antibodies (Ault, 2006). HPV 6 and 11 are the common subtypes correlated 
with genital warts and roughly 90% of the lesions (Braaten & Laufer, 2008).Of the 1% of 
Americans that do have genital warts, there are 13% of those persons that have attended STD 
clinics that do have visible genital warts. Winer et al looked at 148 female college students when 
they began sexual activity, and found a cumulative incidence of HPV 38.9% after 2 years, when 
the infection normally clears (Winer et al., 2003). 
 
Etiology 
Among the 180+ varying strains of HPV, this virus houses itself with the 
papillomaviridae family of noneveloped DNA viruses. The HPV infects keratinocytes by 
overriding the cell’s machinery to devlop progeny viruses. The keratinocyte differention is then 
connected to the HPV replication cycle where proteins early (“E” 1–7) are generatied in non-
differentiated keratinocytes while late proteins (“L” 1 and 2), that are associated with capsid 
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formation are generated to support the sloughing of the HPV. Some HPV strains can be 
transmitted through sexual contact and cause genital warts or warts on other part of the skin. The 
subtypes of HPV are 1, 2, 4, 27, result in cutaneous warts of the hands and feet as with verruca 
vulgaris or verruca plantaris (histology images 1 and 2). Moreover, locations where HPV is 
found relates directly to the strain. Strain 1 normally infects soles of the feet, strain 2 infects the 
palms of the hands, strains 6 and 11 are the cause of genital warts, strains 16 and 18 are 
connected causing cervical cancer. There have been two vaccinces developed for HPV: Gardasil 
for types 6, 11, 16, and 18) with the aim to prevent cervical cancers (Richard and Harris, 2014). 
 
Risk Factors 
The main risk factors for HPV infection depend on the strain of HPV. Overall, risk 
factors are sexual activity, gender and age of first sexual intercourse, smoking, use of oral 
contraceptives for longer than 5 years, chewing betel nut, and exposure to radiation and UV light 
(Luria & Cardoza-Favarato, 2020). The highest rates are consistnetly found in sexually active 
women under the age of 25 (Ault, 2006). Sexual activity ranks as the main risk factor for HPV 
infection, as condoms are useful for preventing a multitude of sexually transmitted diseases, but 
can still leave users susceptible to varying HPV infections. A recent meta analysis reviewed over 
20 trials that reviewed the relationship of condoms and HPV infections. The study concluded 
that condoms do protect against some HPV-related disease, they do not protect against cervical 
infections (Manhart & Koutsky, 2002).  
 
Pathogenesis 
 The antiviral immunity to HPV is dependent upong the NK and CTL immune responses 
(Galluzzi et al., 2012). The two cell populations anihilate their targeted proteins through 
perforin/granzyme-led apoptosis. The immune response for the majority of viral infections 
include the obliteration of virally infected cells alongside minimal inflammation which reflects 
little to no redness, swelling or pus that is seen commonly with bacterial or fungal infections. 
TH1-based cytokines are key in HPV (and viral overall) immunity due to their acceleration of 
CTL reponsses and production of IFN-γ that provide an antiviral effect on the mechanisms at 
hand (Stevanović et al., 2015).  
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The proteins E6 and E7 of HPV will inhibit p53 and Rb, respectively, and are good for 
sensing damaged DNA and repair mechanisms to prevent cell-cycle progression (Grabowska & 
Riemer, 2012). Through protosomeal degredation by way of ubiquitin, E6 and E7 can inihibit 
these ‘genome guardians’ and obstruct the health of the genome and influence improper growth. 
This generates the byproduct of hyperproliferation of keratinocytes to manifest a wart. The HPV 
also avoids antiviral responses regulated by IFN-γ through the E7 protein. This protein can also 
inhibit the promoters of type-I IFN-related genes. It is this reason as to why IFN-alpha is an 
option for treatment of genital warts although patients with high E7 levels have a lower response 
rate than patients with low E7. The E6 protein downregulates IL-18 expression that induces TH1 
and CTL immune responses (Richard & Harris, 2014). 
NK cells in productive antiviral immunity search for the presence or absence of self HLA 
I on cell surfaces, while CTLs in productive antiviral immunity respond to direct HLA-I-peptide 
complexes. With that, HPV’s E5 protein harnesses the ability to downregulate HLA I expression 
by inhibiting tapasin protein and the HLA I promoter binding through transcription factors (de 
Freitas et al., 2017). As the E5 protein lowers the chance of a CTL killing an HPV-infected cell, 
a NK cell still can harnesses the opportunity to do the same. NK cells use their killer activating 
receptors (KARs)  and killer inhibitory receptors (KIRs) to dectect HLA I presences on cellular 
surfaces (de Freitas et al., 2017). Although the balance of positive and negative signals provide 
the NK cells to target the virally infected cells, not many of these populations result in getting 
recruited to the target cell. The virus has sequestered itself inside the highly-localized and 
differentiated keratinocytes of the epidrmis (Richard & Harris, 2014). It is because of the 
superficial keratinocytes that antibody responses are mitigated in HPV due to little to no 
secretion of immunogenic L proteins in quanitites large enough to muster maturation of APCs, 
secrete cytokines and promote effector T-cell activitaiton. Some LHC and APCs can take up 
HPV antigens through phagocytosis or through exosomes, but as HPV is not very inflammatory, 
this occurrence is uncommon (Tindle, 2002). 
 Within the HPV wart, the Langerhan cells produce the CC chemokine ligands CCL17 
and CCL22 that carries the recruitment of CD4+ CD25+ FoxP3+ Treg cells. These Tregs have 
the ability to lower inflammation and contribute to the survival of the HPV and also have been 




Pathology (Gross & microscopic) 
Gross Pathology 
 
Verrucae vulgares type keratotis warts are shown from a patient diagnosed with HPV. The 
anogenital wart of Human papilloma virus, which is traditionally known as the condyloma 
acuminata, serves as a soft, pink, pedunculated papilliferous mass. These masses have a pointy 
and fissured surface that can develop into cauliflower-like lesions in pregnant or 

















The microscopic and wart histology can reveal hyperkeratosis, papillmatosis, and parakeratosis.  
   
(Left) Verruca vulgaris. The lateral rete point toward the center of the lesion. (Right) The plantar 
wart histology demonstrates viral inclusions as the blue dots seen throughtout the slide in 
addition to red, perinuclear keratin inclusion in the skin. (Miteva et al., 2017) 
 
 
Bulbous endo-exophytic acathosis demonstrates a papillomatous surface with the bulbous 
expation of the rete, resembling the branches in a cauliflower. (Miteva et al., 2017) 
 
  
(Left) Condyloma acuminatum. Koilcytes in an HPV lesions appear as shrunked raisin-like 
nuclei. (Right) Bownenoid papulosis. The epidermis takes a ‘windblown’ appearnace due to the 
croweded and atypical keratinocytes, necrotic kerantinocytes and increasd metaphase mitoses. 





Epidermodylsplasia verruciformis (EDV) with blue-grey cells showing a perinuclear halo in the 
stratum spinosum and straum granular layer in verruca plana. (Miteva et al., 2017) 
 
7. Vitiligo 
Incidence & Prevalence 
Vitiligo remains the most popular disorder of pigmentation. As India is representative of 
the most frequent cases of a whopping ~9%, the US’ incidence rate is roughly 1%. In Denmark, 
this disease is studied widely in Denmark, with the largest study orchestrated in 1977, resuting in 
an incidence of 0.38% (Howitz et al., 1977). As of 2012, 1% of the world population is affected 
by vitiligo (Ezzedine et al., 2012). This disease does not favor any specific gender, however, 
more women will address discomfort with their condition, as vitiligo can be categorized as a 
cosmetic problem. Although this condition can arise at any age, ~75% of cases can develop by 
the age of 30. More commonly, this skin disease arises by the age of 12. Vitiligo can develop at 
any age. However, in 70%–80% of cases it arises before the age of 30 (Alikhan et al., 2011). 
Furthermore, an onset before the age of 12 years is common, affecting up to 37% of patients 
(Richard and Harris, 2014). 
 
Etiology 
As there is no exact known cause for vitilitgo, there is the autoimmune hypothesis that 
sits at the foundation of etiology for vitiligo. Other oxidative-stress reated, cytotoxic theories and 
neruohumoral ideals are not supported with much solid evidence. The recent hypotheses are 
surrounding decreased melanocyte survival amd melanocytorrahagy. As many biologists seek to 
understand the source of melanocyte destruction and their subsequent loss in damaged skin, the 
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likelihood of all the supported aforementioned theories playing a role in the etiology is high 
(Alikhan et al., 2011). The convergence of these theories add stress, autoimmunity, mutations, 
acculumation of compound toxicity, and impaired migrtion of melanocytes in the epidermis’ 
basal layer (Le Poole et al., 1993). The autoimmune theory is related to the generalized vitiligo  
while neurohumoral hypothesis (with limited evdience) is related to segmental or focal vitiligo 
(Hann & Lee, 1996). 
Risk Factors (Genetic) 
Genetic abberations are the main players in vitiligo. There are, on average, about 50+ 
genes that are conncted to vitiligo. However, only a few of these genes demonstrate a straight 
link to the dermatosis. The non-HLA genes DDR1, NLRP1, XBP1, PTPN22 and COMT (Njoo 
& Westerhof, 2001). The HLA genes associated with vitiligo are HLA-A2, HLA-DRA4 and 
HLA-DR7 alleles (Singh et al., 2001). The DDR1 gene on locus 6p21 is included into adhering 
melanocytes to the stratum basale through the CCN3 integrin protein (Silva de Castro et al., 
2010). This mutated gene downregulates the adhesion of the cells carrying the melanocytes in 
the basal membrane. Next up, the XBP1 gene on the locus 22q12 can be interruped amidst MHC 
II genes with recent studies indicating elevated levels of XBP1 in lesional skin of vitiligious 
patients as carriers of this gene (Ren et al., 2009).  The risk of generalized vitiligo is correlated to 
a plethora of variations of NLRP1 on  the locus 17p13. Interestingly enough, this gene was first 
to be correlated with American families afflicted with vitiligo (Jin et al., 2007). Additionally the 
PTPN22 gene located on locus 1p13.3-p13.1 is identified as risk factor to generalized vitiligo 
(LaBerge et al., 2008). Finally the COMT gene on the chromosome 22q11.1-q11, relates to 
oxidative stress in vitiligo because of its ability to metabolize catecholamines. In all, these genes 
produce the risk of developing vitiligo (Türsen et al., 2002).  
The last key genetic indicator involves on upwards of 20% of patients with vitligo that 
have a first degree relative afflicted with vitiligo. The relational risk increases by ten-fold with 
patients that have a first-degree sibling with vitligo (Iannella et al., 2016). In African Americans, 
the HLA haplotype that is elevated in this population is the DR4, DQw3 (Dunston & Halder, 
1990). Current studies to elucidate this HLA haplotype in West African population should be 





      Vitiligo is an autoimmune disease that destroys melanocytes from the epidermis, 
affecting patients psychologically on a large scale. There is no preference for gender nor race but 
the disease does prefer the face and genitals, hands and feet, trunk and proximal extremeties. The 
depigmented patches are normally symmetrical outside of segmental vitligo. This vitiligo affects 
about 5% of the global vitiligo patient pool and it’s depigmentation is unileratally localized, 
restrited to the midline/body’s spine.  This is also the main vitiligo for adolescent patients. 
Amongst all vitiligo paitents, there are occasional complaints of itching of the skin’s lesions  
(Taieb & Picardo, 2007) 
This dermatosis is IFN-γ and CTL mediated that is led by a TH1 immune response within 
the dermis. Generally speaking, the majority of autoimmune diseases are difficult to assign 
specific antigens that respond to autoreactive T Cells. The T-Cell receptor in vitiligo is 
determined by specific proteins such as the melanoma atnigen recognized by T- Cells, MART-
1/Melan-A, tyrosinase enzyme that is widely known in melanin production, and gp1000, the 
premelanosome transmembrae protein on the surface of melanocytes (Palermo et al., 2001).  
From histology and clinical representations, vitiligo resembles antitumor and viral 
repsonse as seen in psoriasis. With that, treatments for this condition resort to anti-TNF-alpha 
inhibitors but with little to no avail. Traditional everyday treatments are topical steroids and 
calcineruin inhibitors administered through narrow-band UVB light therapy (Schallreuter et al., 
1999). Currently, emerging therapies utilize IFN-γ with additional TH1 inflammatory pathaway 
mechanisms (Richard and Harris, 2014). 
The autoimmune regulator (AIRE) is generated in the thymus through specialized cells 
and induces (in vitiligo’s case, epidermal) self-antigens to give way for negative selection of 
autoreactive T cells as they develop. When missing this protein, patients are unable to delete 
autoreactive T cells that attack the patients own immune system and leads to a conglomerate of 
autoimmune dermatoses with vitiligo on the list (Tazi-Ahini et al., 2008). 
As the role of anti-melanocyte antibodies in this condition requires further elucidation, 
high levels of autoantibodies have been found in the periphery of 10% of vitiligo patients, 
against tyrosinase one (TRP-1) and tyrosinase two (TRP-2) (Kemp et al., 2011) A vast majority 
of papers demonstrated CD4+ and CD8+ T chells in the DEJ (dermal-epidermal junction) of skin 
surrounding vitiligo lesions, magnifying cell-mediated immunity’s activation in vitiligo (Zhou et 
al., 2012) (Oyarbide-Valencia et al., 2006). Another recent study looked into the presence of 
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CTL that anhiliate melanocyts in skin surrounding vitiligo lesions (van den Boorn et al., 2009), 
and elucidated that HLA-A2 restricted, melanocyte-specific T cells in vitiligo patients are 
correlated to activity of the dermatosis (Lang et al., 2001). Additionally, TREGS have been 
shown in reports to be fundamental in the pathogenesis of vitiligo. When TREGs are reduced in 
the peripheral blood, their lack of uniform acticity increases damage to melanocytes (Dwivedi et 
al., 2015).   
Specific cytokines have been reviewed in vitilgio, as this has been categorized as a TH1 
diseases. The increase of TNF-alpha, which gives reason for the lightly effective anti-TNF-alpha 
inhibitors, IFN-γ, IL-10, and IL-17, which has been found in blood and tissue of vitiligo patients, 
are the main cytokines involved in vitiligo (Speeckaert, Speeckaert & van Geel, 2015). 
Specifically, the activity of IL-17 has in inductive effect on the production of TNF-alpha, which 
adds to the cascade of persistent behavior in this dermatosis (Bassiouny & Shaker, 2011). 
Although there have a variety of pathogenic theories to elucidate the loss of self-tolerance in 
vitiligo, there needs to be further understanding for optimal treatments. 
 
Pathology (Gross & microscopic) 
Vitiligo is characterized by the physical findings in the DEJ and this can be helpful in 
diagnosis of the disease. There are absent melanocytes with negligible inflammatory cells 
infiltrating the tissue. Any active lesions may have a lichneoid presentation. 
Immunohistochemical stains confirm this absence with melanin granules within keratinocytes 
(Gokhale & Mehta, 1983). The melanocytes on the edge of vitiligous skin are often vaculolated 














Perioral vitiligo on a young African American boy with macules and patches of skin around the 
mouth with a lack of pigment. This can be classified as a type of segmental vitiligo as it appears 




Vitiliginous skin (A) houses with only two pan melanoma cells vs unaffected skin (B) with many 
basal keratinocytes that have signficant melaning pigment in them. (Panmelanoma cocktail stain 





We see a slight ridge pattern with suprabasal vacuolization and occasional suprabasal clear 
cells. There are little to no inflammatory cells in the dermis with no melanin visible. 




Table 5: Cytokine-Related Immunopathogenesis of West African Dermatoses.  
The table below includes the 7 statistically signficant diseases and their immune profile 
including cytokines, immune cells, and mediators. As developing immunotherapies are fairly 
de novo in treatment of disease, identifying multi-axis mediators proposes treatments that can 
be utilized. 
 
Skin Disease Immunopathogenesis 
Atopic Dermatitis 
 IL4, IL-5, IL-13, , IL-17, IL-23 induced TH2 cytokine release,   
TH1 cytokine release 
Acne Vulgaris IL-1-alpha, IL-1-beta, IL-12, IL-8, IL-18, IL-17A, IGF-1 increase 
Contact Dermatitis IL-1-alpha, IL-1- beta, IL-6, and IL-8,  IL-12, TNF- alpha 
Urticaria 
IL-6, MMP-9,  IgE-mediated immediate hypersensitivity reaction, 
mast cell-dependent  
Seborrheic Dermatitis 
 CD4+/ CD8+ & TH17 cytokine release 
Human Papillomavirus TH1-cytokines, IFN- γ, downregulates IL-18, CTL responses 
 
Vitiligo IL-10, IL-17, IFN- γ, TNF-alpha, TH1 cytokine release,  TREGs, CTL  
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VII. Discussion and Conclusions 
The dermatoses aforementioned do share the same immunological pathways regardless of 
ethnicity, race, gender, and socioeconomic factors. However, the need for discovery of adequate 
treatment ties back to potential immunotherapies from the immunopathogeneis and cytokine 
profile. Treatment of allergen-related dermatoses such as atopic dermatitis and urticaria, include 
the use of anti-histamines. In regards to acne vulagris, TLR-2 inhibitors (isotretinoin) are used to 
treat severe acne due to the downregulation of TLR-2 that  subsequently is upregulated with 
inflammatory cytokines in response to presence of P.acnes. Vitiligo’s proposed autoimmunity 
has been attempted to mitigate through the use of anti-TNF-alpha inhibitors, due to the 
significant upregulation of TNF-alpha in this disease’s pathogenesis (Alghamdi et al., 2012). 
The general trend from the study reflects significantly higher rates and frequencies of skin 
disease in West Africa with the exception of two dermatoses. Rates of contact dermatitis are 
significatly higher in the United States than in West Africa while rates of the categorical viral 
skin dermatoses (which includes the statisticaly significant  dermatosis, HPV) are significantly 
higher (if not the same) in the United States and in West Africa. As contact dermatitis is 
regularly seen through irritant and allergic contact  dermatitis, it would seem as though the lack 
of identifiable irritants and/or allergens, to connect back to the dermatoses, frequent the West 
African market (Kung, Steenhoff & Gray, 2014). In regards to the only statistically significant 
dermatosis, HPV, rates are slightly higher in the United States. This creates speculation around 
the cultural comfortability of sex as a topic of discussion in Africa that may drive these lower 
rates of reported cases. As there is a connection of human papillomavirus to sexualy activity, 
there may be shame or fear of disciplinary acts upon close friends or family members (Motsomi 
et al., 2016). 
A clear understanding of the immune profile provides way for immunomodulators to pilot 
the treatment and prognosis of disease. However, this immunological treatment plan needs 
further large-scale genome studies (Subramanian, Singh, & Jere, 2018) to understand the specific 
targeted genes amongst West African patients. With the current limited data and varied 
distribution of resources, and heterogeneity of methodology, further studies of rate of incidecne, 
biomedical and computational research, along with clinical treatments can truly provide 
fundamental and consisent treatments in West Africa, to be ethically referenced in treating the 
African diaspora of these same dermatoses. West Africa has been historically known to be 
 
77 
inconsistent with the productioin and distribution of medication and treatments leading to illness 
and even death (Akuse et al., 2012; Polgreen, 2009). West Africa has great potential, but does 
need serious assistance. 
As some diseases are easily preventable and treatable, public health officials and 
epidemiologists can deploy messages to federal and local governing bodies. Providing affordable 
sunscreens while publicly supporting citizen usage can help prevent even exacerbated sequalae 
of most, if not all of the aforementioned dermatoses. By the year 2050, more than 50% of the 
United States will have skin of color (Nijhawan, Jacob, & Woolery-Lloyd, 2008). At the same 
time, the United States’ population will be outnumbered by West Africa, specifically Nigeria, for 
the first time in history However, this number walks alongside the arising issues of disease are 
attributed to the rapid urbanization with poor infrastructure to uphold exponential growth (Aliyu 
& Amadu, 2017). The two occurences in the United States and West Africa reflect as a hint 
toward a global call-to-action to understand the skin disease that will affect a large number of the 
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